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I. INTRODUCTION 
PEPTIC ULCER: 
 Peptic ulcer is one of the most common gastrointestinal disorders, causes 
high rate of morbidity particularly in the population of non-industrialized 
countries1.Peptic ulcer is caused due to an imbalance between the aggressive 
(pepsin, acid, and Helicobacter pylori) and the defensive (gastric mucus and 
bicarbonate secretion, prostaglandins, innate resistance of the mucosal cells) 
factors2. New etiological factors,  such as involvement of free radicals and H. Pylori 
bacteria. 
 Basically, word “peptic” is derived from Greek term “peptikos” whose 
meaning is related to digestion3. Normally, the lining of the stomach and small 
intestine is protected against the irritating acids produced in your stomach. If this 
protective lining breaks off in the continuity it results in inflammation (gastritis) or 
an ulcer4. 
 Peptic ulcer can develop into more serious disorders. As a result of 
complications, peptic ulcer may lead to perforate or bleeding ulcer5.Perforate ulcer 
involves severe tearing of the mucosal membrane, causing acute pain and 
sourness at the abdominal level. Bleeding ulcer involves internal haemorrhages 
and it needs immediate medical intervention. The cause of ulceration in patients is 
mainly due to hypersecretion of gastric juice or due to hypersecretion of pepsin6. 
Less common form of peptic ulcers are zollinger–Ellison syndrome ulcers, drug 
associated ulcers and stress ulcers, H. Pylori. 
 In Ayurveda, peptic ulcer mostly refers to Amlapitta or Parinamasula. 
Amlapitta is a disease of the gastrointestinal tract, especially of the stomach. It has 
not been described as an independent disease in major Ayurvedic texts, but has 
been mentioned in short in Kashyapasamhita. Amlapitta literally means, pitta 
leading to sour taste7.Apart from the stressplaced on food habits and personal 
hygiene, some herbal drugs have also been mentioned in the treatment of this 
disease. 
 Indian medical plants and their derivatives have been shown invaluable 
source of therapeutic agents for the treatment of various disorders including peptic 
ulcer disease. The indigenous drug possessing lesser side effects is the major 
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thrust area of the present day research, aiming for a better and safer approach for 
the management of peptic ulcer diseases. 
REGULATION OF ACID SECRETION BY PARIETAL CELLS8: 
The regulation of acid secretion by parietal cells is especially important in the 
pathogenesis of peptic ulcer. The three major pathways for the regulation of 
parietal acid secretions include. 
1) Neural stimulation in the vagus nerve. 
2) Endocrine stimulation via gastrin released from antral G cells and. 
3) Paracrine stimulation by local release of histamine from enterocromaffin 
like(ECL) cells. 
 The secretion of the parietal cells is an isotonic solution of HCL with pH less 
than 1, the concentration of hydrogen ions being more than a million times higher 
than that of the plasma. The Cl- is actively transported into canacliculi in the cells 
that communicate with the lumen of the gastric glands and thus with the stomach 
itself. This Cl- secretion is accompanied by K+, which is then exchanged for H+ 
from within the cell by a K+/H+ ATPase (fig: 1) . An increase in the permeability of 
the apical membrane to K+ &Cl- accompanies activation of proton pump, the final 
step of HCL production is operated by the gastric proton pump9. 
 
Figure: 1 A schematic illustration of the secretion of HCL by the gastric parietal 
cells. Proton pump (P), Symport carrier (C), Antiport (A) 
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 Carbonic anhydrase catalyses the combination of carbon dioxide and water 
to give carbonic acid, which dissociates into H+ and bicarbonate ions. The latter 
exchange across the basal membrane of the parietal cell for Cl-. The principle 
stimuli acting on the parietal cells are: 
 Gastrin (a stimulatory hormone) 
 Acetylcholine (a stimulatory neurotransmitter) 
 Histamine (a stimulatory local hormone) 
 Prostaglandins E2 and I2 (local hormone that inhibit acid secretion) 
Chemical Mediators: 
Gastrin: 
 Gastrin is a peptide hormone synthesised in endocrine cells of the mucosa 
of the gastric antrum and duodenum, and secreted into the portal blood. Itsmain 
action is to stimulate the secretion of acid by the parietal cells. 
 Gastrin also indirectly increases pepsinogen secretion, stimulates blood flow 
and increases gastric motility. Release of this hormone is normally controlled by 
neurotransmitters and blood brain barriers. 
Acetylcholine: 
 Acetylcholine is released from neurons and stimulates specific muscarinic 
receptors on the surface of the histamine-containing cells. 
Histamine: 
 Within the stomach, mast cells (or histamine containing cells similar to mast 
cells) lying close to the parietal cell release a steady basal release of histamine, 
which is further increased by the gastrin and acetylcholine. The hormone acts on 
the parietal cell H2 receptors, which are responsive to histamine concentrations 
that are the threshold require for vascular H2 receptors activation. The histamine 
inturn activates parietal cells H2 receptors that are linked to the stimulation of 
adenylcyclase causing activation of the cAMP pathway10. 
 The exact mechanism of action of the three secretagogues on the parietal 
cell is not clear. A general scheme is given in Fig: 2, which summarises the two 
main theories: the single cell or permission hypothesis and two cell or transmission 
hypothesis. According to the former concept, the parietal cell itself has H2 
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receptors for histamine and muscarinic M2 receptors for acetylcholine, as well as 
receptors for gastrin itself. Acid secretion as follows after the synergistic of H2 
(which increases cAmp) receptors and M2 and gastrin receptors (which increases 
cytosolic Ca2+) 
 
 
Figure: 2 
CAUSES: 
Helicobacter pylori: 
 H. pylori bacteria lives and multiply within the mucous layer that covers and 
protect tissues that line the stomach and small intestine. Often, H. pylori causes no 
problems. But sometimes it can damage the mucous layer and inflame the lining of 
your stomach or duodenum, leads to formation of ulcer. H. pylorimay be 
transmitted from person to person by close contact, such as kissing. People may 
also contact H. pylori through Water and food 11. 
NSAIDS: 
 NSAIDS are non-steroidal anti-inflammatory drugs. The most commonly 
known NSAIDS are ibuprofen, aspirin, and naproxen sodium. Others are 
prescription NSAIDs used to treat several arthritic conditions. NSAIDS can make 
the stomach's defence mechanisms to fail in a couple of different ways: 
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 They can make the stomach vulnerable to the harmful effects of acid and 
pepsin by interfering with the stomach's ability to produce mucus and 
bicarbonate. 
 NSAIDS can affect cell repair and blood flow to the stomach. 
 The gastric mucosa protects itself from gastric acid with a layer of mucus, 
the secretions are stimulated by certain prostaglandins. NSAIDs block the function 
of COX- 1(cyclooxygenase -1), which is essential for the production of these 
prostaglandins. COX-2 selective anti-inflammatories preferentially inhibit COX-2, 
which is less essential in the gastric mucosa, and roughly have the risk of NSAID - 
related gastric ulceration12. 
ACID AND PEPSIN: 
 Acid and pepsin are powerful digestive fluids and are believed to contribute 
to the formation of ulcers. In ideal situations, the stomach can protect itself from 
these fluids in several ways. These are: 
 The stomach produces lubricant-like mucus that coats the stomach and 
shields stomach tissues. 
 The stomach can produce chemical called bicarbonate that neutralizes 
digestive fluids and breaks them down into less harmful substances. 
 Blood circulation in the lining of the stomach, as well as cell renewal and 
repair, help protect the stomach13. 
SMOKING: 
 Studies show that cigarette smoking can increase a person's chance of 
getting an ulcer.Smoking can also slow down the healing of existing ulcers and 
contributes to ulcer reoccurrence.Smoking by itself may not be much of a risk 
factor unless the presence of H.pylori infection14.  
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ALCOHOL: 
 Alcohol contains chemicals which are similar to the gastric acid that our 
pancreas produce in order to emulsify the food we eat. Alcohol can also contribute 
or trigger to cause gastric wounds in the lining of your stomach causing peptic 
ulcers15. 
STRESS: 
 Emotional stress is no longer thought to be a cause of ulcers, people who 
are experiencing emotional stress often report increased pain of existing ulcers. 
However Physical stress, is different. It can increase the risk of developing ulcers, 
especially in the stomach. Examples of physical stress that can lead to ulcers are 
that suffered by people with injuries such as severe burns, and people undergoing 
major surgery16. 
DIET: 
 No convincing evidence shows that certain diets can cause ulcers or that 
certain diets can heal ulcers and keeps them healed. A diet may help to relieve the 
pain or indigestion of an existing ulcer, but it will not prevent an ulcer from forming. 
Many foods that initially neutralize acid in the stomach also may stimulate 
additional acid secretion. In fact, research has showed that milk, which was a 
mainstay in the diets of ulcer patients, actually can be a potent stimulant of gastric 
acid secretion. Absence of protective factors like fibres in the diet causes peptic 
ulcer17. The accumulation of Histamine and Tyramine in food by microbial action 
and their concentration in various food, wine, beer, and fermented products also 
cause hyperacidity and ulceration. 
BILE REFLUX: 
 The increased concentration of bile salts in stomach interferes with the 
integrity of gastric mucosa thus, predisposing to the development ofulceration18. 
POOR BLOOD SUPPLY: 
 Resistance of mucosa to digestion is reduced as a result of impaired blood 
supply. Such impairment could occur as a result of venous or arterial thrombosis 
or because of “shunting” of blood within the mucosa19. 
 
 7 
 
HEREDITY: 
 A strong family history is frequently found in patients who develop ulcer in 
childhood or adolescence. It was difficult to be certain of the diagnosis of an ulcer 
before radiology was developed and because the prevalence of the condition 
makes the chance association of several cases in a family reasonably probable20. 
SEX INCIDENCE: 
 Duodenal ulcers occur 5-10 times more often in men than in women and the 
perforation is 20 times more often in men. Although, these effects may be due to 
differences in life pattern of men and women, there are grounds for supposing that 
female sex hormones are in some way protective against peptic ulcer21. 
CONSTITUTIONAL FACTORS: 
 There is sexual difference in occurrence of peptic ulcer. Peptic ulcer occurs 
at all ages in men. The incidence is very high (80%) in men compared with women. 
Ulcers are rare in women during there productivity age and particularly during 
pregnancy. Ulcers may occur in women after menopause22. 
OCCUPATION: 
 Duodenal ulcers are found to be more common among the physicians and 
business executives than among other professionals. The incidence is low in 
agricultural labourers. Other factors responsible for ulceration are chronic lung 
diseases, chronic liver diseases and hyper parathyroidism. Number of parietal 
cells present in stomach and hydrochloric acid secretion plays important 
statistically significant role in ulcer formation. Latest information suggests the role 
of bacterial organism, Helicobacter pylori which colonize the gastric mucosa, 
particularly the antral region in the development of chronic ulceration23. 
GASTRITIS: 
 Gastritis precedes the development of the ulcer. Inflammation causes the 
development of ulcer by altering the resistance of mucosa to digestion24. 
CLASSIFICATION OF ULCERS2: 
A peptic ulcer may arise at various locations 
 Stomach (called gastric ulcer) 
 Duodenum (called duodenal ulcer) 
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 Esophagus (called esophageal ulcer) 
 A Meckel’s diverticulum. 
Most Common Types of Ulcers: 
Peptic Ulcer: 
 Any ulcer that is exposed to pepsin is referred to as peptic ulcers. Peptic 
ulcers are found in the lining of your stomach or duodenum. Pepsin is normally 
present along with hydrochloric acid in the stomach lining. 
Gastric Ulcer: 
 When a peptic ulcer is in your stomach, it is called a gastric ulcer. The 
symptoms of gastric ulcers are more specific than peptic ulcer symptoms. 
Duodenal Ulcer: 
 When a peptic ulcer caused in duodenum, it is called a duodenal ulcer. This 
type of peptic ulcer develops in the first part of the small intestine. Some of the 
symptoms of a duodenal ulcer are interestingly quite opposite to those of gastric 
ulcers. Duodenal ulcers are the most common ulcers found in the Western world. 
Lesser Known types of Ulcers: 
Esophageal Ulcer: 
 This type of ulcer occurs in the lower end of your esophagus. Esophageal 
ulcersare often associated with a bad case of acid reflux, as it is commonly called 
(short for Gastro Esophageal Reflux Disease). 
Bleeding Ulcer : 
 Internal bleeding is caused by a peptic ulcer which has been left untreated. 
When this happens, it is referred to as a bleeding ulcer this is the most dangerous 
type of ulcer. Vomiting of blood indicates that a gastric ulcer started bleeding. This 
may also cause repeated episodes of nausea. 
Refractory Ulcer: 
 Refractory ulcers are simply peptic ulcers that have not healed after at least 
3 months of treatment. 
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Stress Ulcer: 
 Stress ulcers are a group of lesions (or lacerations) found in the esophagus, 
stomach or duodenum. These are normally found only in critically ill or severely 
stressed patients. 
SIGNS AND SYMPTOMS25: 
 Pain is the most common symptom of peptic ulcer. Burning pain is the most 
common. The pain caused by the ulcer is aggravated by stomach acid coming in 
contact with the ulcerated area. 
 Abdominal pain, classically epigastric strongly correlated to mealtimes. In 
case of duodenal ulcers the pain appears about three hours after taking a 
meal.(duodenal ulcers are classically relieved by food, while gastric ulcers are 
exacerbated by it) 
Bloating and abdominal fullness; 
 Water brash (rush of saliva after an episode of regurgitation to dilute the acid 
in oesophagus - although this is more associated with gastroesophageal reflux 
disease); 
Nausea, and copious vomiting; 
 Hematemesis (vomiting of blood); this can occur due to bleeding directly 
from a gastric ulcer, or from damage to the esophagus from severe/continuing 
vomiting; 
Loss of appetite and weight loss; 
Melena (tarry, foul-smelling faeces due to oxidized iron from haemoglobin); 
Rarely, an ulcer can lead to a gastric or duodenal perforation, which leads to acute 
peritonitis. This is extremely painful and requires immediate surgery. 
 The symptoms of peptic ulcers may vary with the location of the ulcer and 
the patient's age. Furthermore, typical ulcers tend to heal and recur and as a result 
the pain may occur for few days and weeks and then wane or disappear. Usually, 
children and the elderly do not develop any symptoms unless complications have 
arisen. 
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 The timing of the symptoms in relation to the meal may differentiate between 
gastric and duodenal ulcers. 
 A gastric ulcer would give epigastric pain during the meal, as gastric acid 
production is increased as food enters the stomach. 
 Symptoms of duodenal ulcers would initially be relieved by a meal, as the 
pyloric sphincter closes to concentrate the stomach contents; therefore acid is not 
reaching the duodenum. 
 Duodenal ulcer pain would manifest mostly 2–3 hours after the meal, when 
the stomach begins to release digested food and acid into the duodenum. 
COMPLICATIONS26: 
1. BLEEDING: 
 As an ulcer erodes into the muscular portion of the gastric or duodenal wall, 
it can erode into blood vessels and cause bleeding into the digestive tract. If the 
damaged blood vessels are small, the blood may seep out slowly, and over a long 
period of time, the patient can gradually become anemic. On the other hand, if the 
damaged blood vessel is large, bleeding into the intestinal tract is more rapid and 
can be very dangerous. The patient may feel faint, vomit blood, or collapse 
suddenly. With some bleeding ulcers, the stool may become a tarry black colour 
due to the digested blood it contains. Without prompt medical attention, often 
including blood transfusions and surgery, the patient may bleed to death27. 
 
Figure: 4 
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2. PERFORATION: 
 Sometimes an ulcer will erode all the way through the wall of the stomach or 
duodenum. If this happens, partially digested food and bacteria from the digestive 
tract can spill into the sterile abdominal cavity and cause peritonitis, an 
inflammation of the abdominal cavity and wall. A perforated ulcer, which can cause 
sudden, severe pain, usually requires hospitalization and corrective surgery28. 
3. NARROWING AND OBSTRUCTION: 
 Ulcers that occur in the duodenum or in the narrow section where the 
stomach connects to the duodenum can cause spasms of the adjacent muscles 
and swelling of surrounding tissue. This swelling can cause the intestinal opening 
to become narrowed or closed off completely. Such an obstruction can prevent 
food from leaving the stomach and entering the intestinal tract. A patient may 
vomit the contents of the stomach and, if the condition continues, lose weight and 
develop other problems. Again, surgery may be necessary to correct this problem. 
DIAGNOSIS29, 30: 
 Esophagogastroduodenoscopy (EGD) a form of endoscopy, also known as a 
gastro copy in which a fiber optic tube with an attached camera is threaded down 
the throat and esophagus into stomach and duodenum. With this sensitive method, 
the upper digestive tract is viewed, ulcer can be identified. 
 Upper gastro intestinal (upper GI) X-ray which involves swallowing a white 
metallic liquid (containing barium) that coats the digestive tract and makes an 
ulcer more visible. 
 Direct culture from an EGD biopsy specimen. The specimen is examined 
under a microscope to rule out cancer. A biopsy can also identify the presence 
of H.pylori in stomach lining 
 Direct detection of urease activity in biopsy specimen-Rapid urease test (CLO 
test). 
H. pylori infection is most commonly diagnosed with following tests: 
 Blood test (Serological tests): IgG antibodies against H.pylori can be 
detected inthe serum using laboratory based and near patient testing serology 
kits. 
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A disadvantage of this test is that it sometimes can’t differentiate between part 
exposure and current infection. After H. pylori bacteria has been eradicated, still a 
positive result may be obtained for many months. 
 Breath test: Isotopically labelled carbon dioxide can be detected in the breath 
ofH. pylori positive individuals following ingestion of urea labelled with 13C or 
14C.
 
TREATMENT OF PEPTIC ULCER2: 
1. Reduction of gastric acid secretion : 
a) H2-antihistamines :Cimetidine, Ranitidine, Famotidine, Roxatidine, Loxatidine 
b) Proton pump inhibitors :Omeprazole, Lansoprazole, Pantoprazole, 
Rabeprazole, Esomeprazole 
c) Anticholinergics: Pirenzepine, Propantheline, Oxyphenonium 
d) Prostaglandin analogues:Misoprostol, Enprostil, Rioprostil 
2. Neutralization of gastric acid (antacids) : 
a) Systemic  : Sodium bicarbonate, Sodium citrate 
b) Non systemic : Magnesium hydroxide, Magnesium trisilicate, Aluminium 
hydroxide gel, Magaldrate, Calcium carbonate 
3. Ulcer protective : Sucralfate, Colloidal bismuth subcitrate (CBS) 
4. Ulcer healing drugs  : Carbenozolone Sodium 
5. Anti H-Pylori drugs: Amoxycillin, Clarithromycin, Metronidazole, Tinidazole, 
Tetracycline. 
MECHANISM OF ACTION: 
 H2 receptor antagonists: These drugs act by competitively inhibit histamine 
actionsat all H2 receptors, but their main clinical use are as inhibitors of gastric 
acid secretion. They can inhibit histamine, gastrin, and acetylcholine stimulated 
acid secretion; pepsin secretion also falls with the reduction in volume of 
gastric juice. 
 Proton pump inhibitors: The parietal cells secrete H+with the help of a 
membranelocated enzyme H+ K+ ATPase called as proton pump or an acid 
pump. These drugs inhibit the proton pump and abolish HCl secretion. The 
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drug is a week base andaccumulates in the acid environment of the canaliculi 
of the stimulated parietal cell were it is activated. 
 Anti cholinergic drugs: There drugs acts as selective antagonist at 
M1muscarinicreceptors. These drugs reduce the volume of gastric juice without 
raising its pH unless there is food in stomach to dilute the secreted acid. 
Stimulated gastric secretion is less completely inhibited. 
 
 Prostaglandin analogues: PGE and PGI reduce the secretion of gastric acid 
and atlower concentrations may promote cytoprotection. Inhibit gastrin 
production, increase mucosal blood flow and probably have an ill-defined 
"cytoprotective" action. However, the most important appears to be their ability 
to reinforce the mucus layer covering gastric and duodenal mucosa which is 
buffered by HCQ] secreted into this layer by the underlying epithelial cells. 
 
Figure: 5 
 Systemic antacids: They are absorbed into the systemic circulation and 
causealkalosis. It is water soluble, acts instaneously, but the duration of action 
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is short. It is a potent neutralizer, pH may rise above 7 However, it has several 
demerits: 
 Absorbed systemically: large doses will induce alkalosis 
 Acid rebound occurs, but is usually short lasting 
 Produces C02 in stomach distention, discomfort, belching, risk of ulcer 
perforation. 
 Increases Na+ load: may worsen edema and contraindicated in cardiac 
diseases 
 Non-systemic antacids: In stomach, the cation of the antacid forms a 
chlorideduring neutralization of the acid. In the alkaline pH of small intestine, 
the chloride salt reacts with the bicarbonate from the intestinal juices to 
regenerate original salt. Hence systemic alkalosis is avoided 
 Ulcer protective’s: They precipitate surface proteins at an ulcer base and acts 
as anacid resistant physical barrier preventing acid, pepsin and bile from 
coming in contact with the ulcers. 
 Ulcer healing drugs: They cause greater production of gastric mucus by 
increasingendogenous PG which has a protective and coating action. 
SCREENING METHODOLOGIES FOR ANTIULCER ACTIVITY: 
In Vivo Methods: 
1. Pylorus Ligation In Rats (Shay model) 
2. Stress Ulcer Through Immobilization Stress 
3. Stress Ulcers By Cold Water Immersion 
4. Indomethacin Induced Ulcers In Rats 
5. Ethanol Induced Mucosal Damage In Rats (Cytoprotective Activity) 
6. Subacute Gastric Ulcer In Rats 
7. Gastric Ischemia-Reperfusion Injury In Rats 
1. Pylorus ligation in rats (SHAY) : 
Male or Female Wistar strain albino rats weighing 150-170g are starved for 
48 hrs, having access to drinking water and libitum. During this time they are 
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housed single in cages with raised bottoms of wide wire mesh in order to avoid 
cannibalism and coprophagy. Sixanimals are used per dose and as controls. 
Under ether anesthesia a midline abdominal incision is made. The pylorus is 
ligated, care being exercised that neither damage to the blood supply nor traction 
on the pylorus occurs. Grasping the stomach with instruments is to be meticulously 
avoided; else ulceration will invariably develop at such points. The abdominal wall 
is closed by sutures. The test compounds are given either orally by gavage or 
injected subcutaneously. 
The animals are placed for 19hrs in plastic cylinders with an inner diameter 
of 45 mm being closed on both ends by wire mesh. Afterwards, the animals are 
sacrificed in CO2anesthesia. The abdomen is opened and a ligature is placed 
around the esophagus close to the diaphragm. The stomach is removed and the 
contents are drained in a centrifuge tube. Along the greater curvature the stomach 
is opened and pinned on a cork plate. The mucosa is examined with a 
stereomicroscope. In the rat, the upper two fifths of the stomach form the Lumen 
with squamous epithelium and posses little protective mechanisms against the 
corrosive action of gastric juice. Below a limiting ridge, in the glandular portion of 
the stomach, the protective mechanisms are better in the mucosa of the medium 
two fifths of the stomach than in the lower part, forming the antrum. Therefore, 
lesions occur mainly in the lumen and in the antrum. The number of ulcers is noted 
and the severity recorded with the following scores 
 O = no ulcers 
 1 = superficial ulcers 
 2 = deep ulcers 
 3 = perforation 
 The volume of the gastric content is measured. After centrifugation, acidity is 
determined by titration with 0.1 N NaOH. 
2. Stress ulcer through remobilization stress: 
Groups of 6 female Wistar rats per dose of test drug and for controls 
weighing 150-170g are used. Food and water are withdrawn 24hrs before the 
experiment. After oral or subcutaneous administration of the test compound or the 
placebo solution the animals are slightly anaesthetized with ether. Both lower and 
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upper extremities are fixed together and the animals are wrapped in wire gaze. 
They are horizontally suspended in the dark at 20C for 24 hrs. and finally 
sacrificed in CO2anesthesia. The stomach is removed, fixed on a cork plate and 
the number and severity of ulcers in registered with a stereo microscope using the 
following scores. 
 0 – no ulcers 
 1 – Superficial ulcers 
 2 – Deep ulcers 
 3– Perforation 
3. Stress ulcers by cold water immersion: 
Groups of 8–10 Wistar rats weighing 150-200g are used. After oral 
administration of the test compound the rats are placed vertically in individual 
restraint cages in water at 22C for one hour. Then, they are removed, dried and 
injected intravenously via the tail vein with 30mg/kg Evans blue. Ten min later, 
they are sacrificed in CO2anesthesia and their stomachs removed. Normal saline 
(2% v/v) is then injected into the totally ligated stomachs for storage overnight. The 
next day, the stomachs are opened along the greatest curvature, washed in warm 
water and examined under a 3-fold magnifier. The lengths of the longest diameters 
of the lesions are measured and summated to give a total lesion score (in mm) for 
each animal, the mean count for each group being calculated. 
4. Indomethacin induced ulcers in rats: 
Groups of 6 Wistar rats weighing 150-200g are used. The test drugs are 
administered orally in 0.1% Tween 80 solution 10 min prior to oral indomethacin in 
a dose of 20 mg/kg (4mg/ml dissolved in 0.1% Tween 80 solution). Six hours later, 
the rats are sacrificed in CO2anesthesia and their stomachs removed. Normal – 
saline (2% v/v) is then injected into the totally ligated stomachs for storage 
overnight. The next day the stomachs are opened along the greater curvature, 
then washed in warm water and examined under a 3-fold magnifier. The lengths of 
the longest diameters of the lesions are measured and summated to give a total 
lesion score (in mm) for each animal, the mean count for each group being 
calculated. 
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5. Ethanol induced mucosal damage in rats: 
Male Wistar rats weighing 250-300g are deprived of food 18 hours prior to 
the experiment but are allowed free access to water. During this time they are kept 
in restraining cages to prevent coprophagy. The rats are administered either the 
appropriate vehicle or the cytoprotective drug eg: a prostanoid, intragastrally 
30min prior to administration of 1ml absolute ethanol. Untreated animals are 
included as controls. One hour after administration of ethanol, the animals are 
euthanized with CO2 the stomachs are excised, cut along the greater curvature, 
and gently rinsed under tap water. The stomachs are stretched on a piece of foam 
core mat, mucosal site up. The subjective scores of the treated tissues are 
recorded, the graded response is reflected the least (0) to most (3) damage. A 
circular full thickness area, about 13mm in diameter, is cut with a cork borer from 
each lobe of the fundus just below the ridge dividing the glandular from the non-
glandular portion of the stomach. A Plexiglas template (19 x 14 x 0.3cm) burnished 
on one side with emery cloth and with four rows with six holes 13mm in diameter is 
placed on a sheet of clear glass, burnished side up, and bound to the glass with 
photographic tape along the periphery. The excised pairs of tissue from each 
stomach are placed into the holes of the template. 
Pairs of tissue from each stomach are examined to minimize sampling 
errors. The template is positioned on a rectangular central open area of Aristo 
model T-16 cold cathodes transilluminator (38 x38 cm) containing a W-45 blue 
white lamp. A camera is mounted on a copy stand directly above the template. 
Photographs are taken; the film processed in a standard manner and a contact 
sheet is made from the negatives. A light transmission densitometer (eg: MacBeth 
model TD.501) is used to evaluate the negatives. The optical density of the test 
tissues is determined by placing each area of the negative in sequence over the 
aperture through which the light is transmitted. The optical density is displayed on 
a digital read out and recorded. Hemorrhagic or damaged areas appease bright on 
the negative whereas undamaged tissue appears dark. Hence, lower optical 
density values are indicative of damage while higher optical densities are 
associated with little or as in the case of control, no damage. 
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6. Subacute gastric ulcer in rats: 
Female Wistar rats weighing 120-150g are fasted for 24 hrs. having access 
to water at libitum in cages with wire sieves at the bottom. The rats are 
anaesthetized with either and a polyethylene catheter including a fine steel wire 
with a needle tip (1.2mm diameter) at the lower end is orally inserted into the 
stomach. After the cannula reaches the gastric wall, the upper end of the steel wire 
is pressed in a definitive manner, so as to puncture the gastric wall. Each rat is 
kept in the same position during the intervention in order to locally the puncture at 
nearly the same region of the glandular part of the stomach. The test substances 
are administered orally, 30mm or 24 hrs after puncture. Free access to food and 
water is provided from 2 hours upto the end of the experiment. Each group 
consists of 8-15 rats. 
The animals are sacrificed by overdose of either at definitive time intervals 
after puncture. The stomach is dissected and opened along the lesser curvature, 
extensively rinsed in tap water and fixed to the end of a polyethylene tube of 
10mm diameter (plastic tip of anautomatic pipette) in or position with the punched 
ulcer in the centre. The end of the tube with the gastric wall is suspended in a 
beaker containing physiological saline and the pressure in the tube is gradually 
increased with a valued rubber ball connected to other end of the tube. The third 
part of the system is a tonometer calibrated upto 1 bar. The value of tension at 
which bubbles appear at the ulcerous gastric wall is noted. This value is termed as 
tensile strength and can be expressed in mmHg. 
7. Cysteamine - induced duodenal ulcers in rats: 
Male Sprague-Dawley rats with an initial weight of 200g are used. Cysteamine HCl 
is administered three times on day 1 in a dose of 280mg/kg orally. Protective drugs 
such as H2-antagonists are given 30 min prior cysteamine treatment. The rats are 
sacrificed on the third day. For histological evaluation, the stomach and duodenum 
are fixed in 10% aqueous buffered formaldehyde and paraffin embedded sections 
are stained with hematoxylin and eosin. Duodenal ulcers develop in the anterior 
(antimesentesic) and posterior wall of the proximal duodenum, about 2-4 mm from 
the pylorus. The more sever ulcers, located on the anterior wall, frequently 
perforate, resulting in focal or generalized peritonitis or penetrate into the liver. The 
opposite ulcer invariably penetrates into the pancreas. 
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In Vitro Method: 
Objective:- 
 To investigate the mechanism of action of a series of potential combination 
therapies for use against H. pylori. 
Design:- 
 The effects of certain antiulcer agents on the antimicrobial activity of 
antibioticseffective against H. pyloriwere determined In-vitro. 
Procedure:- 
H.pyloriwas cultured on Skirrow’s agar. Amoxycillin Clarithromycin, Erythromycin & 
Tetracycline were used. 
The Antiulcer agents studied by measuring the urease activity. 
Urease activity was measured by the urease- indophenol method. The minimum 
inhibitory concentration was determined by a plating method, with H.pylori 
streaked on plates containing various concentrations of the antibiotics plus 
sublethal doses of the antiulcer agents, which may be evaluated for the Antiulcer 
activity. 
OXIDATIVE STRESS 
A free radical is defined as a molecule or molecular fragments containing one or 
more unpaired electrons in its outermost atomic or molecular orbital and capable 
of independent existence31. Reactive oxygen species (ROS) and reactive nitrogen 
species (RNS) are describes free radicals and other non-radical reactive 
derivatives. The reactivity of radicals is generally stronger than non-radical species 
though radicals are less stable32. 
Free radicals are highly reactive due to the presence of unpaired electrons. Free 
radicals those are formed during normal metabolism are involved in both human 
health diseases. 
Free radicals are involved in 
 Enzyme catalyzed reactions 
 Signal transduction and gene expression 
 Activation of nuclear transcription factors 
 Electron transport in mitochondria 
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 Oxidative damage to cells , molecules, and tissues 
 Anti-microbial action of neutrophils and macrophages 
 Aging and disease. 
 Normal metabolism is dependent upon oxygen, a free radical. Through 
evaluation, oxygen was chosen as the terminal electron acceptor for respiration. 
The two unpaired electrons of oxygen spin in the same direction; thus, oxygen is a 
bi radical, but is not a very dangerous free radical. Other oxygen derived free 
radical species, such as super oxide or hydroxyl radicals, formed during 
metabolism or by ionizing radiation are strong oxidants and are therefore more 
dangerous33. 
In general pro oxidants are referred to as reactive oxygen species. Oxygen 
derived pro oxidants, which can cause damage to biological target such as 
 Lipids 
 DNA 
 Proteins 
 Otherdefending systems of composed of enzymes and reducing 
equivalents34. 
REACTIVE SPECIES INVOLVED IN OXIDATIVE STRESS AND IMPORTANT 
ROLE OF FREE RADICALS: 
Reactive species mainly classified into three groups: 
 Reactive oxygen species 
 Reactive nitrogen species 
 Reactive chlorine species35 
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Table: 1 Reactive species involved in oxidative stress.  
Type Radicals Non radicals 
ROS Super oxide, O2 .- Hydrogenperoxide,H2O2, 
 Hydroxyl OH.- Hypochlorus acid, HOCl; 
 Peroxyl RO2., Ozone O3; 
 Alkoxyl RO2., Single oxygen 
1O2  . 
 Hydro Peroxyl HO2.  
RNS Nitric oxide (nitric monoxide) NO. Nitrous acid HNO2 
 Nitrogen dioxide, NO2. Nitrosyl cation NO
+, 
  Nitrosyl anion NO- 
  Peroxy nitrite ONOOH 
  Alkyl Peroxy nitrite ROONO 
RCS Atomic chlorine ,Cl. Hypochlorus acid HOCl 
  Chlorine Cl2 
  Nitronium chloride NO2Cl 
 
 At high concentrations, ROS can be important mediators of damage to cell 
structures, nucleic acids, lipids and proteins36. O2
• − radical is responsible for lipid 
peroxidation and also have the capability to decrease the activity of other 
antioxidant defense system enzyme such as catalase (CAT) and glutathione 
peroxide (GPx), it causes damage to the ribonucleotide which is required for DNA 
synthesis. OH• radical is most reactive chemical species. It is a potent cytotoxic 
agent and able to attack and damage almost every molecule found in living tissue. 
H2O2 is not a radical but it produces toxicity to cell by causing DNA damage, 
membrane disruption and release calcium ions within cell, resulting in calcium 
dependent proteolytic enzyme to be activated. HOCl isproduced by the enzyme 
myeloperoxidase in activated neutrophils and initiates the deactivation of 
antiproteases and activation of latent proteases leading to tissue damage37. 
 Super oxide (O2
.-) generated in mitochondria, in CVS and others. Fig 6 b) 
Cells of the immune system (neutrophils, macro phases) also produce the super 
oxide anion because they contain membrane bound enzyme complex, respiratory 
burst characterized by an increases in oxygen consumption which is accompanied 
by an increase in glucose utilization and production of NADPH by the pentose 
phosphate pathway. The NADPH oxidize that reduces oxygen to super oxide 
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anion once the super oxide anion is formed it can be converted to hydrogen 
peroxide by the enzyme super oxide dismutase and then it convert to hypochlorus 
acid by the enzyme myeloperoxidise which can further react with super oxide 
anion to form the hydroxyl radical. These final products are essential for bacterial 
killing. Hydroxyl radical very highly reactive, generated during iron over load and 
such conditions in our body. Hydrogen peroxide formed in our body by large 
number reactions and yields potent like.OH38.  
Peroxyl radical reactive and formed from lipids, proteins, DNA, sugars etc 
during oxidative damage. Organic hydrogen peroxide reacts with transit metal ions 
to yield reactive species. Single oxygen highly reactive formed during 
photosensitization and chemical reactions. 
 Reactive nitrogen species (RNS) is also a collective term including nitric 
oxide and nitrogen dioxide radicals and such non radicals as HNO2; ONOOH is 
often classified as both RNS and ROS. Nitric oxide it is one of neurotransmitter 
and blood pressure regulator can yield potent oxidants during pathological states. 
React quickly with almost everything. RO2
. NO2
. And ONOOH have intermediate 
reactivities. 
 Nitric oxide is produced in biological tissue by nitric oxide synthase which act 
as a catalyst to convert L-arginine and oxygen to nitric oxide. Nitric oxide has both 
pro-oxidant, anti-oxidant properties. For example a nitric oxide radical can both 
stimulate and inhibit lipid peroxidation. HOCl and NO2Cl can also be classified as 
reactive chlorine species are HOCl and NO2Cl
.39. 
Fig: 6 a) showing the chemical reaction between nitric oxide and super oxide 
anion from the highly damaging Peroxy nitrile. Addition of a proton to the Peroxy 
nitrile leads to the formation of Peroxy nitrous acid. Activated Peroxy nitrous acid 
can either leads to substrate oxidation and nitration or simply rearrange to nitrate 
in the absence of adequate substrate34. 
SOURCES OF FREE RADICALS37, 40: 
The cell is exposed to a large variety of ROS and RNS from both exogenous 
and endogenous sources. 
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Endogenous Sources: 
 The primary source is from our body during the energy production process 
within the cells. 98% of the oxygen we breathe is used within our cells in the 
production of energy. The resultant effect of this energy producing activity is 
that a very small amount of oxygen that was not used losses electrons 
creating free radicals. 
 Food that we consume may have a destructive potential. An example would 
be fried foods in high temperature, which causes the bonds in the molecule 
to become unstable. 
 Low blood supply – generally occurs during heart attacks and strokes – 
forms free radicals. 
 During normal metabolism of fat, carbohydrates and proteins, Free radicals 
may created in the body. 
 Stress especially oxidative stress. All chemicals and some endocrine 
hormones create free radicals. 
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Exogenous Sources: 
 UV radiations, X-rays, gamma rays and microwave radiation. 
 Environmental contaminants such as pollution. Cigarette smoke in particular 
increases free radical load tremendously. 
 Unhealthy foods – processed foods, fried foods, barbecued and charbroiled 
foods. 
 Excessive or over-exercising. 
 Toxic products found in furniture polish and paints eg., toluene, benzene and 
formaldehyde 
 Industrial effluents, excess chemicals, alcoholic intake, certain drugs, asbestos, 
certain pesticides and herbicides, some metal ions, fungal toxins and 
xenobiotics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure: 7 
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BIO MARKERS OR SPECIFIC TARGETS OF OXIDATIVE STRESS: 
LIPIDS: ROS attack cellular components involving PUFA residue of 
phospholipids,which extremely sensitive to oxidation. Once formed peroxyl 
radicals can be re arranged via recyclisation reaction to end peroxide, being MDA 
the final product. Lipid peroxidation involves LDL as well as HDL oxidation. The 
process of LP gives many products of toxicological interest like MDA, 4- HNE and 
various 2 alkenals. 
PROTEINS: The side chains of amino acids residues of protein are susceptible 
tooxidation by the ROS. The protein carbonyl group is generated by ROS through 
many different mechanisms and its concentration is a good measure of protein 
oxidation via oxidative stress. The nitric oxide reacts rapidly with O2
. - to form the 
highly toxic ONOO-that is able o- nitro sate the cystien SH groups of proteins, to 
nitrate tyrosine and tryptophan residues of proteins and to oxidize methionine 
residues to methionine sulfoxide. Oxidation of protein is associated with a number 
of age related diseases and aging. 
DNA: Oxidative DNA modifications are frequent in mammalian and have been 
asimportant contributory factors to the mechanism of carcinogenesis, diabetes and 
natural aging .The DNA damages are considered as the most serious ROS 
induced cellular modifications as DNA is not synthesized denovo but copied, 
perpetuating by this way those modifications and hence inducing mutations and 
genetic instability. The main responsible free radicals such as .OH and H. react 
with DNA by addition to bases of hydrogen atoms from the sugar moiety. The C4-
C5 double bond of pyrimidine is particularly sensitive to attack by .OH generating a 
spectrum of oxidative pyrimidine damage products. Including thymine glycol, uracil 
glycol 5-OHdU, 5-OHdC, and others. Similarly interact with purine will generate 8-
OHdG, 8-OHdA, and other purine oxidative products. Several repair pathway 
repair DNA damage.8-OHdG has been implicated in diabetes and carcinogenesis 
and is considered reliable marker for oxidative DNA damage. 
CARBOHYDRATES: Free radicals such as.OH react with carbohydrates by 
randomlyabstracting a hydrogen atom from one of the carbon atoms, producing a 
carbon centered radical. This leads to chain breaks in important molecules like 
hyaluronic acid in the synovial fluid surrounding joints, an accumulation and 
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activation of neutrophils during inflammation produces significant amount of oxy 
radicals that is also being implicated in rheumatoid arthritis. 
OTHER DAMAGES: Oxidative damage to the mitochondrial membrane can also 
occurresulting in membrane of depolarization and the uncoupling of oxidative 
phosphorylation with altered cellular respiration. This can ultimately lead to 
mitochondrial damage, with release of cytochrome c, activation of apoptosis. 
REACTIVE OXYGEN SPECIES INDUCED CELLULAR OXIDATIVE 
DAMAGE: 
The continuous efflux of ROS from endogenous exogenous sources results in 
continuous and accumulative oxidative damage to cellular components and alters 
many cellular functions. Among the biological targets most vulnerable to oxidative 
are proteinaceous enzymes, lipidic membrane, and DNA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure: 8 ROS induced oxidative damage. 
Reactive nitrogen species (RNS) like nitric oxide free radical is probably 
insufficiently reactive to attack DNA. Directly by contrast, di nitrogen trioxide and 
Peroxy nitrile can lead to deamination of and nitration of DNA. Living organisms 
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therefore have evolved enzymes that can remove deamination products of 
Cytosine (Uracil), Adenine (Hypoxanthine) and Guanine (Xanthine) from DNA to 
decrease the risk of mutagenesis. Excess intra gastric production of RNS (e.g. as 
result of H.pylori infection chronic 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure: 9 List of disorders caused by oxidative stress 
 
ANTI OXIDANT DEFENSE SYSTEM: 
Antioxidants are any substance that delay or inhibits oxidative damage 
(oxidation) to a target molecule. The anti oxidant defense which is in action to 
protect cellular homeostasis against harmful ROS produced during normal cellular 
metabolism as well as pathological state. Anti oxidant can scavenge free radicals 
by accepting or donating an electron to eliminate in unpaired condition in most 
cases the scavenger molecule provides hydrogen radical that combines with free 
radical. Its generated new radicals thus an enhanced life time compared with the 
starting one for instance due to a conjugated system. The extended lifetime of this 
radical by formation of new molecule and thus one scavenger molecule can 
eliminate second radical. 
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Many components act against free radicals to neutralize them from both 
endogenous and exogenous in origin41. 
Endogenous anti oxidants: Super Oxide Dismutase (SOD), Catalase 
(CAT),Glutathione Peroxidase (GSH-PX), Glutathione Reductase (GR) 
Exogenous anti oxidants: vitamin A and vitamin E & C. 
 Super oxide dismutase SOD (scavenging anti oxidant) is an important 
endogenousantioxidant enzyme act as the first line defence system against 
ROS which scavenges superoxide radicals to H2O2. 
 Glutathione Peroxidase (GSH-PX) present in the cytoplasm of the cells 
removes H2O2 by coupling its reduction to H2O with oxidation of Glutathione 
(GSH). SH groups present in GSH to react with H2O2 and the OH• radical and 
prevent tissue damage andGSH is also capable of scavenging ROS directly or 
enzymatically via GSH-Px. 
 Catalase is a water soluble enzyme. Catalase metabolize H2O2 to H20 and O2. 
GSH – PX reduced both H202 and organic hydro peroxides when reacting with 
GSH42, 43. 
Table No.: 2 Endogenous antioxidant defences 
Antioxidant 
enzyme 
Chemical 
name 
Scavenged 
oxidant agent 
General characters 
GSH-PX 
Glutathione 
Peroxidase 
H202 
It is major endogenous 
antioxidant molecule 
SOD 
Super oxide 
dismutase 
O2.- 
Necessary for the release of 
biological 
Active NO it protects NO 
from inactivation. 
CAT Catalase H202 
It catalyses the breakdown 
of H2O2 to   H2Oand 
molecular oxygen. 
Various antioxidants with different functions play their roles in the defense 
network, the free radical scavenging antioxidants being one of the 
players.Preventing antioxidant functions as first line defense by suppressing the 
formation ROS/RNS. Scavenging antioxidants remove active species rapidly by 
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the active species attack biologically essential molecules (SOD). Various enzyme 
functions by third line defence by repairing damages, clearing the wastes and 
reconstituting the lost function. Adaptation mechanism fourth line defence, in which 
appropriate antioxidants are generated at right time and transferred to right 
position right concentration44.Exogenous antioxidants such as Vitamin E, Vitamin 
C, exist at a number of locations namely on the cell membrane, intracellular, extra 
cellular membrane. They react with ROS to either or remove or inhibit ROS. Fat 
soluble antioxidants like vitamin E protect against the loss of membrane integrity. 
Fat soluble antioxidants are important in preventing membrane PUFA from 
undamaging lipid peroxidation44, 45. 
ROLE OF FREE RADICALS IN PEPTIC ULCER46: 
Peptic ulcers affect the gastrointestinal tract. Malignancies of the G.I. tract 
are relatively resistant to radiation therapy and chemotherapy has also had modest 
benefit, whereas an effective therapy still remains elusive in the treatment of 
gastroduodenal ulceration. One of the common cause of these diseases is the 
involvement of free radicals. Reactive oxygen species (ROS) are generated from 
numerous normal metabolic processes and are needed for normal functioning of 
the organism. Various antioxidant enzymes like SOD, GSH-PX, and CAT control 
their accumulation. If there imbalance in the activity of these enzymes leads to 
formation of free radicals. These ROS are responsible for oxidation of DNA and 
causes tissue damage. Antioxidants seemed to have protective role in gastric 
ulcers and carcinomas47. 
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II. AIM AND OBJECTIVE 
AIM  
The aim of this study is to evaluate the Antiulcer effect of Echinops 
echinatus Roxb.,on acetic acid and methylene blue induced ulcerations.  
PROPOSED OBJECTIVE: 
Herbs are the major contributors in the drug discovery which would be even 
cheap and safe. So we selected medicinal herbs. The plants were selected based 
on the ethno botanical claim. Based on the sequence of preliminary screening the 
total protocol was adopted for plants Echinops Echinatus Roxb., To get better 
components in the extract, ethanolic extraction was used. 
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III. REVIEW OF LITERATURE 
Literature review of Echinops Echinatus Roxb. 
i. Sofia Eram et al., (2016) carried out Experimental evaluation of Echinops 
echinatus as an effective hepatoprotective. Ethanolic extract of ariel parts of 
Echinops echinatus were evaluated on CCl4 induced liver damage in Rabbits, 
the extract at the dose level of 500 mg/kg is found to posses significant 
protection. 
ii. Manish Agrawal et al., (2012) evaluated the protective effects of Echinops 
echinatus on testosterone-induced prostatic hyperplasia in rats. Echinops 
echinatus extracts attenuated the increase in the prostatic/body weight ratio 
induced by testosterone. Butanolic fraction of ethanolic extract at the dose 
level of 50 and 100 mg/kg exhibited the best activity. 
iii. Amish J. Patel et al., (2011) performed Comparative diuretic activity of root 
and aerial part methanolic extracts of Echinops echinatus Roxb.Methanolic 
extracts of roots and aerial parts of Echinops echinatus Roxb. were subjected 
to diuretic potential in albino rats methanolic extracts at the dose of 250 and 
500 mg/kg body weight shows a significant increase in the urine volume and 
electrolyte excretion when compared to control. 
iv. Leena S & Sitaram K (2010) discussed Traditional uses of plants as cooling 
agents by the tribal and traditional communities of dang region in Rajasthan, 
India. Echinops echinatus Roxb. paste smeared on soles and palms to treat 
heatstroke. 
v. Rudrappa JN & Mohmoud R (2010) studied Free radical scavenging activity 
of Echinops echinatus roxb Root. Extracts of Echinops echinatus Roxb, roots 
were evaluated for radical scavenging activities using different in vitro models 
like scavenging of 2, 2 diphenyl-1-picrylhydrazyl (DPPH) radical, nitric oxide 
radical and superoxide anion. 
vi. Singh S et al., (2006) isolated Flavonoids from Echinops echinatus. A new 
isoflavone glycoside, echinoside (7), together with 7-hydroxyisoflavone, 
kaempferol-4'-methylether, kaempferol-7-methyl ether, myrecetin-3-O-alpha-
L-rhamnoside, kaempferol and kaempferol-3-O-alpha-L-rhamnoside, has 
been isolated from the whole plant of Echinops echinatus.  
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vii. Padashetty SA & Mishra SH (2005) described antifertility activity of 
Echinops echinatus roots on male rats. The present study was undertaken to 
evaluate the effect of terpenoidal fraction prepared from the petroleum ether 
extract of the roots of Echinops echinatus on male reproductive parameters.  
viii. Khan MA et al., (2000) discussed Ethnobotany and taxonomic studies of 
Echinops echinatus Roxb. (Untkatara) from Potohar region of Pakistan. The 
ethnobotanical information was verified by cross-checking with the people of 
different localities. The plant is diuretic, alterative, aphrodisiac and nervine 
tonic. It is also recommended in hysteria, dyspepsia, jaundice and scrofula.  
ix. Singh B et al., (1999) described anti-inflammatory activity of ethanol extract 
of Echinops echinatus whole plant. The extract effectively inhibited the acute 
inflammation induced in rats by carrageenan, formaldehyde and adjuvant and 
the chronic arthritis induced by formaldehyde and adjuvant.  
x. Singh UP et al., (1998) investigated antifungal activity of some new flavones 
and flavone glycosides of echinops echinatus. Four phenolic compounds, viz., 
apigenin, apigenin-7-O-glucoside, echinacin, and echinaticin, were isolated 
from the whole plant of Echinops echinatus Roxb.; the latter two compounds 
were isolated for the first time. Echinacin, which was highly effective at 150 
μg mL−1, is considered the most promising of these compounds and its use 
as a control measure against Alternaria blight of pigeon pea under field 
conditions has been suggested. 
xi. Bupinder Sing et al., (1989) investigated Anti-inflammatory activity of 
taraxasterol acetate from Echinops echinatus in rats and mice. Taraxasterol 
acetate, a triterpenoid found in several plant species, demonstrated 
antiinflammatory activity in albino rats against carrageenan, formaldehyde 
and adjuvant induced inflammations in doses between 10 and 100 mg/kg. 
xii. Chaudhuri et al., (1987) isolated Echinozolinone, an alkaloid from Echinops 
echinatus. In addition to echinopsine and echinopsidine, a new alkaloid, 
echinozolinone, has been identified in Echinops echinatus as 3(2-
hydroxyethyl)-4(3H)-quinazolinone from its spectral data.  
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IV. SCOPE AND PLAN OF WORK 
SCOPE OF WORK 
Gastric ulcer is one of the commonest diseases, Peptic ulcer disease is a 
serious gastrointestinal disease it requires a well targeted strategy. A number of 
drugs including proton pump inhibitors, prostaglandins analogs, histamine receptor 
antagonists and cytoprotective agents are available for the treatment of peptic 
ulcer. Reports on clinical evaluation of these drugs show that there are incidences 
of relapses and adverse effects and danger of drug interactions during ulcer 
therapy. This is been the rational for the development of new antiulcer drug and 
the search for novel molecules has been extended to herbal drugs that offer better 
protection and decreased relapse. 
Several natural drugs have been reported on anti-ulcerogenic activity by 
virtue of their predominant effect on mucosal defensive factors. Plants and other 
natural substances has been used as the rich source of medicine. Ancient 
civilizations have documented medical uses of plant in their own ethnobotanical 
texts. The list of drugs obtained from different plant source is fairly extensive. 
PLAN OF THE WORK 
The following studies were carried out on ethanolic extract of Echinops 
echinatus Roxb. 
i. Collection and authentification of plant. 
ii. Preparation of ethanolic extracts and preliminary phytochemical 
screening of extracts.   
iii. In-vitro antioxidant studies of the extracts.  
a. Determination of DPPH radical scavenging activity. 
b. Determination of nitric oxide scavenging activity. 
c. Determination of hydroxyl radical scavenging activity. 
iv. Toxicological investigation of the extracts. 
a. Acute toxicity study.  
b. Sub acute toxicity. 
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v. Antiulcer studies  
a. Acetic acid induced gastric ulcer method  
b. Methylene blue induced gastric ulcer method   
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V. MATERIALS AND METHODS 
PLANT MATERIALS  
The whole plant material for the plant EchinopsEchinatus Roxb were 
collected from the forest regions of tirupathi and were authenticated by Prof. P. 
Jayaraman, Director, National Institute of Herbal Science, Chennai. The Ref. no. 
PARC/-2018/043 respectively. 
PLANT: 
Scientific name  : EchinopsechinatusRoxb. 
Family   : Compositae / Asteraceae  
 
Botanical Classification 
 Kingdom   : Plantae           
 Division   : Magnoliophyta 
 Class     : Echinops 
 Sub class   : Tracheobionta 
 Order    : Yet to know 
 Genus   : Echinops 
 Species   : Echinatus 
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Vernacular Names 
 English   : Indian Globe Thistle  
 Sanskrit   : Brahmadanda 
 Tamil    : Kutiraippijan 
 Hindi    : Utakatira, Oontkateli, Gokhru 
 Kannada   : Brahmadande  
 Telugu   : Brahmadandi 
Habitat 
India -  Andhra Pradesh, Bihar, Himachal Pradesh, Jammu  and   Kashmir,  
Karnataka,  Madhya Pradesh,  Maharashtra, Rajasthan, Tamil Nadu, Uttar 
Pradesh, West Bengal 
 
 
Traditional Uses  
The rural population of Gujarat uses the suspension of root bark powder for the 
treatment of diabetes. Chhattisgarh people use this herb in different ways both 
internally and externally for the treatment of sexual disorders. The patients 
suffering from respiratory troubles, particularly asthma, are advised to inhale the 
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fumes obtained by burning the leaves & roots of E. echinatus in order to get quick 
and permanent relief. The root is abortifacient aphrodisiac. The seeds are sweet 
and aphrodisiac. The plant is bitter, stomachic, antipyretic, analgesic, increases 
the appetite stimulates the liver, useful in brain disease, used in ophthalmia, 
chronic fever, pains in the joints, inflammations, the root is aphrodisiac. 
EXPERIMENTAL ANIMALS 
Albino wistar rats of either sex approximately same age group were used 
after being acclimatized for a week at laboratory conditions. They were provided 
standard rodent pellet diet (Lipton India) and water ad libitum. The animals had 
free access to food and water and maintained under 12:12 hr light and dark cycle. 
All experiments were carried out during day time. The protocol was approved by 
institutional animal ethical committee and care of the animals was taken as per 
guidelines of committee for the purpose of control and supervision in experiments 
on animals (CPCSEA), representative of animal welfare, Govt of India. 
The experimental protocol was approved by the Institutional Animal ethics 
Committee IAEC Ref. No. SVCE/BIO/2018/011 
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CHEMICALS: 
S.No Chemicals Source 
1 
Acetic  acid Sigma chemical company, USA 
2 Acetyl  thiocholine iodide  S.d.fine chemicals Ltd.,Mumbai 
3 Adenosine 5’ diphosphate S.d.fine chemicals Ltd.,Mumbai 
4 Chloroform S.d.fine chemicals Ltd., Mumbai 
5 Disodium hydrogen phosphate S.d.fine chemicals Ltd., Mumbai 
6 5,5’-Dithio-bis-2-nitrobenzoic 
acid(DTNB) 
Loba chemicals Ltd, Mumbai. 
7 Disodium dihydrogen phosphate. S.d.fine chemicals Ltd.,Mumbai 
8 Ethyl Acetate S.d.fine chemicals Ltd.,Mumbai 
9 Ethylene diamine tetra acetic acid 
(EDTA) Disodium. Salt 
Rolex lab reagent, Mumbai. 
10 FeCl3 reagent S.d.fine chemicals Ltd., Mumbai 
11 Glycine S.d.fine chemicals Ltd., Mumbai 
12 Glutamate dehydrogenase  S.d.fine chemicals Ltd., Mumbai 
13 Hydrogen peroxide Qualigens  fine chemicals Ltd., 
Mumbai 
14 Hydrazine hydrate S.d.fine chemicals Ltd..Mumbai 
15 Iodine S.d.fine chemicals Ltd.,Mumbai 
16 Methanol ( analytical grade) S.d.fine chemicals Ltd., Mumbai 
17 n-butanol S.d.fine chemicals Ltd.,Mumbai 
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18 NAD (Nicotinamide adenine 
dinucleotide) 
S.d.fine chemicals Ltd., aiMumb 
19 NADPH2 S.d.fine chemicals Ltd., Mumbai 
20 Oxidised gluthathione. Qualigens  fine chemicals Ltd., 
Mumbai. 
21 Potassium dihydrogen phosphate S.d.fine chemicals Ltd., Mumbai 
22 Pthalyl dialdehyde. S.d.fine chemicals Ltd., Mumbai 
23 Perchloric acid Loba chemicals Ltd, Mumbai. 
24 Pyrogallol S.d.fine chemicals Ltd., Mumbai  
25 Reduced Glutathione (GSH) S.d.fine chemicals Ltd., Mumbai  
26 Sodium dodecyl sulphate(SDS) S.d.fine chemicals Ltd., Mumbai  
27 Sodium Acetate S.d.fine chemicals Ltd., Mumbai  
28 Sodium hydrogen carbonate S.d.fine chemicals Ltd., Mumbai  
29 Thionyl chloride. S.d.fine chemicals Ltd., Mumbai  
30 Trichloro acetic acid Ranbaxy laboratories Ltd. 
Chemical division, New delhi. 
31 Tris HCl S.d.fine chemicals Ltd., Mumbai 
32 Thiobarbituric acid Rolex laboratories reagent, 
Mumbai 
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Extraction and Identification of Phytoconstituents  
Extraction of plant material (Harbone 1973) 
The air dried parts of Echinops Echinatus Roxb., 500gms each were coarse 
powdered and extracted with 50% alcohol. The crude extract was further filtered 
and evaporated by the aid of rotary evaporator. The final mass is weighed and 
preserved for further use.   
Preliminary phytochemical screening:  
Preliminary phytoconstituents present in the hydroalcholic extract of 
Echinops Echinatus plants were identified based on the chemical test. (Kokate 
CK1994) 
1. Test for alkaloids  
 Treated with dilute Hydrochloric acid and filtered. The filtrate was treated 
with various alkaloidal agents. 
a) Mayer’s–Test  
 Treated with Mayer’s reagent and cream colour indicates the presence of 
alkaloid. 
b) Dragendroff’s–Test 
 When little amount of the sample was treated with the Dragendroff’s 
reagent, the presence of reddish brown precipitate reveals the presence of 
alkaloid. 
c) Hager’s–Test  
 Treated with the Hager’s reagent and presence of yellow colour precipitate 
indicates the presence of alkaloid. 
d) Wagner’s–Test 
 Treated with the Wagner’s reagent, the appearance of brown colour 
precipitate indicates the presence of alkaloid. 
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2. Test for carbohydrates  
The extracts were treated with 3ml of alpha–Napthol in alcohol and to the sides 
of the test tube concentrated sulphuric acid was added carefully. Formation of 
violet colour ring at the junction of two liquids shows the presence of 
carbohydrates.  
a) Fehling’s–Test  
The extracts were treated with Fehling’s solution A and B and heated. Presence 
of reddish brown colour precipitate indicates the presence of reducing sugars. 
b) Benedict’s–Test  
The extracts were treated with Benedict’s reagent and heated and presence of 
reddish orange colour precipitate indicates the presence of reducing sugars. 
c) Barfoed’s–Test  
The extracts were treated with Barfoed’s reagent and heated. Appearance of 
reddish orange colour precipitate indicates the presence of non reducing sugars. 
3. Test for proteins  
a) Biuret’s–test  
When the extracts were treated with copper sulphate solution, followed by the 
addition of sodium hydroxide solution, appearance of violet colour indicates the 
presence of proteins 
b) Millon’s–Test  
When the extract was treated with Millon’s reagent, appearance of pink colour 
indicates the presence of proteins. 
 
4. Test for steroids  
a) Libermann Burchard Test  
When the extracts were treated with concentrated sulphuric acid, few drops of 
glacial acetic acid, followed by the addition of acetic anhydride, appearance of 
green colour indicates the presence of steroids. 
 
 42 
 
 
5. Test for sterols  
When the extracts were treated with 5% potassium hydroxide solution, 
appearance of pink colour indicates the presence of sterols. 
6. Test for phenols  
When the extracts were treated with neutral ferric chloride solution, appearance 
of violet colour indicates the presence of phenols. 
When the extracts were treated with 10% sodium chloride solution, the 
appearance of cream colour indicates the presence of phenols. 
7. Test for tannins  
a) When the extracts were treated with 10% lead acetate solution, appearance of 
white precipitate indicates the presence of tannins. 
b) When the extracts were treated with aqueous bromine solution, appearance of 
white precipitateindicates the presence of tannins. 
8. Test for flavanoids  
a) 5ml of the extract solution was hydrolyzed with 10 % v/v sulphuric acid and 
cooled. Then, it was extracted with diethyl ether and divided into three portions 
in three separate test tubes. 1 ml of diluted sodium carbonate, 1 ml of 0.1N 
sodium hydroxide, and 1ml of strong ammonia solution were added to the first, 
second and third test tubes respectively. In each test tube, development of 
yellow color demonstrated the presence of flavonoids. 
b) Shinoda's test 
The extract was dissolved in alcohol, to that one piece of magnesium followed 
by concentrated HCl was added drop wise and heated. Appearance of magenta 
color shows the presence of flavonoids. 
9. Test for gums and mucilage  
The extracts were treated with 25 ml of absolute alcohol, and then solution was 
filtered. The filtrate was examined for its swelling properties. 
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10. Test for glycosides  
 When a pinch of the extracts were dissolved in the glacial acetic acid and 
few drops of ferric chloride solution was added, followed by the addition of 
concentrated sulphuric acid, formation of red ring at the junction of two liquids 
indicates the presence of glycosides. 
11. Test for saponins  
Foam test 
 1ml of the extracts are diluted to 20 ml with distilled water and shaken well 
in a test tube. The formation of foam in the upper part of the test tube indicates 
the presence of saponins. 
5.6  TOXICITY STUDY 
5.6.1 Acute oral toxicity study (OECD 423)50 
For carrying out oral toxicity study OECD guidelines 423 was followed.  It is 
a stepwise procedure with three animals of a single sex per step.  Depending on 
the mortality and/or, 50, 300, 2000mg/kg body weight and the results allow a 
substance to be ranked morbidity of the animals a few steps may be necessary to 
judge the toxicity of the test substance.  This procedure has advantage over other 
methods because of minimal usage of animals while allowing for acceptable data. 
The method uses defined doses (5and classified according to the globally 
harmonized system. The starting dose for ethanolic extract was 2000mg/kg 
bodyweight (p.o).  The dose was administered to the rats which were fasted 
overnight with water ad libitum and observed for signs of toxicity.  The same dose 
was once again tried with another three rats and were observed for 72 hours for 
symptoms like change in skin colour, salivation, diarrhea, sleep, tremors, 
convulsions and also respiratory,  autonomic  and  CNS effects. 
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Fig-3 Flow Chart for acute toxic class method (OECD guidelines 423) at starting 
dose of 2000 mg/kg body weight/p.o 
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SUB ACUTE TOXICITY STUDY 
For carrying out sub acute oral toxicity study OECD guidelines 407 -Repeated 
Dose 28-Day oral toxicity study in rodents was followed.  The duration of the Study 
was 28 days. Three dose levels of the plant extract were used (200 & 400 mg/kg). 
Each group consists of ten animals. The drug was administered orally once daily for 28 
days. On 29th day the animals was anaesthetized and blood was collected by retro 
orbital puncture. Hematological parameters were evaluated. Serum was separated and 
biochemical parameters were estimated. Animals were sacrificed and organs were 
removed and weighed. The organs were kept in 10% formalin and used for histo-
pathological analysis. 
Change in body weight 
The change in body weight was observed for a time period of 28 days at an 
interval of 7 days. Body weight gains were determined from the final and initial body 
weights52 
Organ weight  
After sacrifice, organs were quickly excised and weighed (absolute organ 
weight and relative organ weights were computed. ((Liver weight : Body weight) x 100) 
HAEMATOLOGICAL STUDIES 
The following haematological parameters were estimated by standard 
procedures. 
Total R.B.C. count 
The enumeration of red blood corpuscles was carried out on blood samples 
using haemocytometer as per standard methods.  The blood was taken in the R.B.C. 
pipette upto 0.5 marks and diluted with R.B.C. diluting fluid (Hyme’s fluid) upto 101 
marks.  It was mixed well and mounted on counting chamber.  The red blood cells 
were then counted using a haemocytometer and their number in undiluted blood was 
calculated.  R.B.C. count in blood is expressed as cells in millions/mm3.58 
Total W.B.C. Count 
The blood was taken in W.B.C. pipette upto 0.5 mark and diluted with W.B.C. 
diluting fluid (1-2% acetic acid stained lightly with gentian violet), where acetic acid 
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destroy the red blood corpuscles and gentian violet stains the nuclei of white blood 
cells.  The fluid in the pipette was mixed well and mounted in the counting chamber.  
The W.B.C. count was then counted and their number in undiluted blood was 
calculated.  W.B.C. count in blood is expressed as cells in 1000/mm3.61 
Differential leukocyte count 
 A blood film stained with Leishman’s stain was examined under oil immersion 
and the different types of blood cells were identified.  The percentage distribution of 
these cells was then determined as follows: 
 A thin blood film was prepared, dried and placed on the staining rack and was 
covered with Leishman’s stain and allowed to stand for 2mins.  Then equal volumes of 
distilled water was added and mixed by tilting the slide first-one way and then the other 
way.  It was allowed to stand for 6mins, drained off diluted stain in a stream of distilled 
water from a wash bottle for about 20 seconds and allowed the slide to remain on the 
rack for 1-2mins with the last wash covering it.  The slide was kept against a support in 
an inclining position, stained the smear facing down and allowed to dry. 
Then the stained slides were studied under low and high power objectives for 
differential counts by placing two drops of cedar wood oil on the stained smear and 
using oil-immersion lens.  The differential count is expressed as percentage for 
neutrophils, lymphocytes, eosinophils, monocytes and basophils.63 
Haemoglobin (Hb) concentration 
Haemoglobin in the red blood corpuscles was converted to acid haematin by 
adding N/10 hydrochloric acid. The brown colour developed was matched against 
standard brown tinted glass in the comparator by direct vision.  The haemoglobin 
concentration in blood is expressed as grams per 100 ml of blood (g%).65 
BIOCHEMICAL STUDIES:  
Blood samples were drawn by cardiac puncture. Blood from three animals was 
pooled for serum separation. Each serum sample was analyzed by auto analyzer   
i. Aspartate Aminotransferase (ASAT) 
ii. Alanine Aminotransferase (ALAT) 
iii. Alkaline Phosphatase (ALP) 
iv. Total Bilirubin (TB) 
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v. Direct Bilirubin (DB) 
vi. Urea 
vii. Creatinine 
viii. Total protein. 
HISTOPATHOLOGICAL STUDY 
After blood collection rats were sacrificed for histopathology studies. The internal 
organs like liver, kidney, lungs, brain, heart and spleen were isolated and blotted free 
of blood, weighed immediately to determine relative organs weight and observed for 
gross lesions. Histological examination was performed on the tissue preserved in 10% 
buffered formalin solution with particular emphasis on those which showed gross 
pathological changes.67 
Liver and kidneys were evaluated for histopathological changes. After collection of 
organs, the tissues were stored in 10% formalin for 48 hrs. The solution was changed 
after 24hrs. In the case of kidneys, two incomplete parallel cuts were made from cortex 
to pelvis and one longitudinal cut was made which divides the kidney into two halves. 
In case of liver one piece from each lobe was used. The tissues were then wax 
embedded as below: 
 Solvent            Duration (Holding Period) 
 50% Alcohol      30 minutes 
 70% Alcohol       30 minutes 
 95% Alcohol       20 minutes 
 95% Alcohol       20 minutes 
 100% Alcohol     30 minutes 
 100% Alcohol     30 minutes 
 Chloroform          30 minutes 
 Chloroform          30 minutes 
 Wax      10 minutes 
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They were then blocked in wax and allowed to set on a cold plate. Once cooled they 
were cut into 5µ size sections. The sections were kept in slides and stained with 
haematoxyline and eosin.  
 
EVALUATION OF ANTI ULCER ACTIVITY  
ACETIC ACID INDUCED ULCERS  
Rats were divided in to 4 groups (n=6) and the duration of the experiment was 7 days. 
Groups Treatment 
Group-I Rats received normal distilled water for 7 days. 
Group-II 
Rats received Omeprazole 20mg/kg with dilute acetic acid (4%) (2 ml) 
submucosal injection after the 7th day 
Group –III 
Rats received 200 mg/kg EE oral with dilute acetic acid (4%) (2 ml) 
submucosal injection after the 7th day 
Group –IV 
Rats received 400 mg/kg EE oral with dilute acetic acid (4%) (2 ml) 
submucosal injection after the 7th day 
At the end of the treatment period, rats were deprived of food overnight and sacrificed 
on day 8th day by light ether anesthesia followed by decapitation after recording the 
final body weight. Blood was collected from each rat for biochemical estimation and 
stomach along with duodenum was quickly isolated immersed in ice cold saline and 
weighed.   
Acetic Acid-Induced Gastric Ulcers 
Gastric ulcer induced in rats by means of submucosal injection of acetic acid and 
reported on the healing process of lesions for extended intervals after the ulcer 
preparation.20 
The procedure for inducing ulcers by acetic acid involves fasting rats for 24–36 hours 
with access to water ad libitum. The animals are observed to ensure good health 
before induction of ulcers. First, the animals are put under light ether anesthesia. A 
flexible plastic catheter with an outside diameter of 2 mm is inserted 8 cm into the 
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colon via the anus through which dilute acetic acid (4%) (2 ml) is introduced into the 
colon. The rats are then maintained in a head-down position for 2 minutes to prevent 
leakage of the acetic acid solution. After 24 hours of acetic acid administration, the 
animals are started the treatment with ethanolic extract of Echinops echinatusRoxb.  
[61]. It is prudent to conduct a preliminary dose-finding study to determine optimum 
dose for ulcer induction. 
METHYLENE BLUE-INDUCED ULCER 
To induce ulcers with MB, animals are fasted 24 hours before MB 
administration at a dosage of 125 mg/kg body weight p.o. followed by the 
administration of the drug(s) or substances under investigation. Animals are sacrificed 
after 4 hours of MB administration, and ulcer index determined 
 
Rats were divided in to 4 groups (n=6) and the duration of the experiment was 7 days. 
Groups Treatment 
Group-I Rats received normal distilled water for 7 days. 
Group-II 
Rats received Omeprazole 20 mg/kg with MB administration at a dosage 
of 125 mg/kg after the 7th day 
Group –III 
Rats received 200 mg/kg EE oral with MB administration at a dosage of 
125 mg/kg after the 7th day 
Group –IV 
Rats received 400 mg/kg EE oral with MB administration at a dosage of 
125 mg/kg after the 7th day 
 
At the end of the treatment period, rats were deprived of food overnight and sacrificed 
on day 
Ulcer Scoring 
After sacrificing the rat, stomach was removed and opened along the greater curvature, 
and washed it slowly under running tap water. Put it on the glass slide and observe 
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under 10X magnification for ulcer. Score the ulcers as below. 0= normal coloured 
stomach 
 0  =  no damage 
 1  =  blood at the lumen 
 2  =  pinpoint erosions  
 3  =  one to five small erosions <2 mm,  
 4  =  more than five small erosions <2 mm,  
 5  =  one to three large erosions >2 mm,  
 6  =  more than three large erosions >2 mm 
Mean ulcer score for each animal is expressed as Ulcer Index. 
Free acidity and Total acidity. 
One ml of gastric juice is pipette in to 100ml conical flask and titrate with 0.01N NaOH 
using topfers reagent as an indicator. (It is Dimethyl-amino-azo-benzene with 
phenolphthalein and used for detection and estimation of hydrochloric acid and total 
acidity in gastric fluids) Titrate to end point when the solution turns to orange colour. 
Note the volume of NaOH which corresponds to free acidity. Titrate further till the 
solution regains its pink colour. Note the total volume of NaOH which corresponds to 
the total acidity. Acidity (mEq/L/100 g) can be expressed as 
Acidity= 
𝑣𝑜𝑙𝑢𝑚𝑒𝑜𝑓𝑁𝑎𝑜𝐻×𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑡𝑦𝑜𝑓𝑁𝑎𝑜𝐻 
×100 
     100 
INVITRO ANTI-OXIDANT ACTIVITY 
DPPH Radical Scavenging Assay(78): 
 The DPPH free radical is reduced to a corresponding hydrazine when it reacts 
with hydrogen donors. The DPPH radical is purple in colour and upon reaction with 
hydrogen donor changes to yellow colour. It is a discoloration assay, which is 
evaluated by the addition of the antioxidant to a DPPH solution in ethanol or methanol 
and the decrease in absorbance was measured at 490nm. 
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 Reagents: 2, 2-Diphenly 1-picryl hydrazyl solution (DPPH, 100 M): 22 mg of 
DPPH was accurately weighed and dissolved in 100 ml of methanol. From this stock 
solution, 18 ml was taken and diluted to 100 ml using methanol to obtain 100 M DPPH 
solution. 
 Preparation of test solution: 21mg each of the extract was dissolved in distilled 
DMSO separately to obtain solutions of 21 mg/ml concentrations. Each of these 
solutions was serially diluted separately to obtain lower concentrations 
 Preparation of standard solutions: 10 mg each of ascorbic acid and rutin were 
weighed separately and dissolved in 0.95 ml of Dimethyl sulfoxide (DMSO) to get 10.5 
mg/ml concentrations. These solutions were serially diluted with DMSO to get lower 
concentrations. 
Procedure: The assay was carried out in a 96 well microtitre plate. To 200 l of DPPH 
solution, 10 Ml of each of the test sample or the standard solution was added 
separately in wells of the microtitre plate. The final concentration of the test and 
standard solutions used were 1000, 500, 250, 125, 62.5, 31.25 and 15.625, 7.812 
g/ml. The plates were incubated at 37o C for 30 min and the absorbance of each 
solution was measured at 490 nm, using a micro plate reader. 
% of inhibition   = 
Absorbance of control–Absorbance Test  
 X 100 
 Absorbance of control  
SCAVENGING OF NITRIC OXIDE RADICAL: 
 Sodium nitroprusside in aqueous solution at physiological pH spontaneously 
generates nitric oxide, which interacts with oxygen to produce nitrite ions, which can 
be estimated by the use of modified Griess Ilosvay reaction. In the present 
investigation, Griess Ilosvay reagent is modified by using Naphthyl ethylene Diamine 
Dihydro chloride (0.1% w/v) instead of 1-napthylamine (5%). Nitrite ions react with 
Griess reagent, which forms a purple azo dye. In presence of test components, likely 
to be scavengers, the amount of nitrites will decrease. The degree of decrease in the 
formation of purple azo dye will reflect the extent of scavenging. The absorbance of 
the chromophore formed was measured at 540 nm79, 80. 
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a ) Reagents: 
Sodium nitroprusside solution:  Weighed accurately  0.2998   g  of  sodium 
nitroprusside and dissolved in distilled water to make up the volume to 100 ml in a 
volumetric flask (10 mM). 
Naphthyl Ethylene Diamine Di hydrochloride (NEDD, 0.1%): 
Weighed accurately 0.1 g of NEDD and dissolved in 60 ml of 50% glacial acetic acid 
by heating and made up the volume to 100 ml in a volumetric flask with distilled water. 
Sulphanilic acid (0.33% w/v) reagent: 
Weighed accurately 0.33 g of sulphanilic acid and dissolved in 20% glacial acetic acid 
by heating and made up the volume to 100 ml in a volumetric flask. 
Preparation of test sample: The sample solution was prepared as described in DPPH 
assay. 
Preparation of standard solutions: 
Weighed accurately 10 mg of ascorbic acid and rutin and dissolved in 1 ml of DMSO 
separately. From these solutions, serial dilutions were made to obtain lower 
concentrations using DMSO. 
Procedure: The reaction mixture (6 ml) containing sodium nitroprusside (10 mM, 4 ml), 
phosphate buffer saline (PBS, pH 7.4, 1 ml) and extract in DMSO at various 
concentrations or standard was incubated at 25o C for 150 min. After incubation, 0.5 
ml of the reaction mixture containing nitrite ion was removed, 1 ml of sulphanilic acid 
reagent was added, mixed well and allowed to stand for 5 min for completion of 
diazotization. Then, 1 ml of NEDD was added, mixed and allowed to stand for 30 min 
in diffused light. A pink coloured chromophore was formed. The absorbance of these 
solutions was measured at 540 nm. 
 
% of inhibition   = 
          Absorbance of Control– Absorbance Test     
                  Absorbance of Control 
X 100 
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VI. RESULTS 
 
Percentage Yield of Leaf Extract: 
 
 The yield obtained from the ethanolic extract of EchinopsEchinatus Roxb was 
about 12gms from 500gms of dried plant. 
 
The percentage yield of extract = 2.4% 
 
PRELIMINARY PHYTOCHEMICAL STUDIES: 
 
The Results of preliminary Phytochemical Screening of the ethanolic extract of 
EchinopsEchinatus Roxb were given in Table 3. It shows presence of 
 
Alkaloid, Flavonoids, Glycosides, Phytosterols, Triterpenoids, Tannins and Proteins 
 
 
Sl.No Test EE 
1 
Test for carbohydrates 
Molisch’s test 
Absent 
2 
Test for Alkaloids 
Mayer’s test 
Dragendrodroff’s test 
Present 
3 
Test for Flavonoids 
Alkaline reagent test 
Present 
4 
Test for Glycosides 
Modified Borntrager’s test 
Keller- Killiani test 
Present 
5 
Leiberman-Bucharat test 
Salkowaski test 
Present 
6 Test for Tannins Present 
7 Test for Proteins Present 
 
Table: 3. Preliminary Phytochemical Screening of the ethanolic extract of 
Echinopsechinatus Roxb 
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ACUTE TOXICITY STUDIES 
 
The treatment of animals with Ethanolic extracts of EchinopsEchinatus has not shown 
any changes in autonomic or behavioural responses in rats. There is no mortality upto 
2000mg/kg body weight. 
 
S. No Parameters Result 
1 Motor activity Absent 
2 Tremors Absent 
3 Convulsion Absent 
4 Straub reaction Absent 
5 Pilo erection Absent 
6 Loss of lighting effects Absent 
7 Sedation Absent 
8 Muscle relaxation Absent 
9 Hypnosis Absent 
10 Analgesia Absent 
11 Ptosis Absent 
12 Lacrimation Absent 
13 Diarrhoea Absent 
14 Change in skin colour No change 
 
Table no: 4 observation on acute toxicity studies at the dose of 2000mg/kg 
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Parameters 
observed  
Day-1 Day-2 Day-3 Day-4 Day-5 Day-6 Day-7 Day-8 Day-9 Day-10 Day-11 Day-12 Day-13 Day-14 
Aggressiveness + + + + + + + + + + + + + + 
Alertness - - - - - - - - - - - - - - 
Alopecia  - - - - - - - - - - - - - - 
Circling  - - - - - - - - - - - - - - 
Diarrhoea - - - - - - - - - - - - - - 
Edema - - - - - - - - - - - - - - 
Eye closure at touch  + + + + + + + + + + + + + + 
Grip strength + + + + + + + + + + + + + + 
Grooming  + + + + + + + + + + + + + + 
Lacrimation - - - - - - - - - - - - - - 
Loss of writing reflex - - - - - - - - - - - - - - 
Mortality  - - - - - - - - - - - - - - 
Nasal sniffing  - - - - - - - - - - - - - - 
Piloerection - - - - - - - - - - - - - - 
Rearing  - - - - - - - - - - - - - - 
Righting reflex - - - - - - - - - - - - - - 
Seizures - - - - - - - - - - - - - - 
Straub tail - - - - - - - - - - - - - - 
Urine stains  - - - - - - - - - - - - - - 
 
6.3.2 Observation in acute toxicity studies at the dose of 2000mg/kg bw p.o dose of Anisomeles malabarica (L.) 
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I. SUB-ACUTE TOXICITY STUDIES 
 Sub-acute toxicity studies were carried out according to OECD 407 and rats were divided into groups of 10 animals (5 male 
and 5 female). The suspension of ethanolic extract was administered to rats at the dose of 100 & 200 mg/kg/day for 28 days. The 
toxic symptoms such as signs of toxicity, mortality and body weight changes were monitored. Rats were anesthetized with ether at 
the end of the treatment period. All rats were sacrificed after the blood collection. 
Parameters 
observed  
Day-
2 
Day-
4 
Day-
6 
Day-
8 
Day-
10 
Day-
12 
Day-
14 
Day-
16 
Day-
18 
Day-
20 
Day-
22 
Day-
24 
Day-
26 
Day-
28 
Aggressiveness + + + + + + + + + + + + + + 
Alertness - - - - - - - - - - - - - - 
Alopecia  - - - - - - - - - - - - - - 
Circling  - - - - - - - - - - - - - - 
Diarrhoea - - - - - - - - - - - - - - 
Edema - - - - - - - - - - - - - - 
Eye closure at 
touch  
+ + + + + + + + + + + + + + 
Grip strength + + + + + + + + + + + + + + 
Grooming  + + + + + + + + + + + + + + 
Lacrimation - - - - - - - - - - - - - - 
Loss of writing 
reflex 
- - - - - - - - - - - - - - 
Mortality  - - - - - - - - - - - - - - 
Nasal sniffing  - - - - - - - - - - - - - - 
Piloerection - - - - - - - - - - - - - - 
Rearing  - - - - - - - - - - - - - - 
Righting reflex - - - - - - - - - - - - - - 
Seizures - - - - - - - - - - - - - - 
Straub tail - - - - - - - - - - - - - - 
Urine stains  - - - - - - - - - - - - - - 
6.3.3 Signs of toxicity in sub acute toxicity (28 days) 
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CHANGE IN BODY WEIGHT  
 
Treatment 0th day 5th day 10th  day 15st day 20th day 25th day 28th day % increase 
Control 175.83±6.84 179.50±6.28 181.83±6.46 184.83±6.31 187.16±6.01 190.66±6.46 193.66±5.70 10.3637 
100mg/kg 177.00±4.43 180.50±4.47 182.83±5.02 186.16±5.40 190.00±6.04 192.500±5.70 195.500±5.63 10.1695 
200mg/kg 177.16±8.02 178.83±8.17 182.83±8.23 186.00±7.85 189.000±8.11 192.16±8.43 194.83±8.34 09.6044 
 
6.3.4 Change in body weight after the drug treatment EchinopsEchinatus Roxb 
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6.3.5  Haematological Parameter 
 
Haematological parameter Control EchinopsEchinatus Roxb 
200 mg 400mg 
Total R.B.C. count (×106 
mm−3). 
9.09±0.15 8.90±0.12 9.11±0.16 
Total W.B.C. Count (×103 
mm−3). 
12.67±0.22 12.35±0.15 11.23±0.23 
Haemoglobin (Hb) (g/dl) 15.61±0.36 14.07±0.30 15.63±0.36 
Hematocrit (%). 44.21±1.01 43.61± 1.72 36.4±1.36 
Platelets (×103 mm−3). 834.91±24.01 867.21±23.25 739.81±26.86 
Lymphocytes(%). 84.7±1.32 81.8±1.33 72.8±1.43 
Neutrophils (%). 20.6±0.65 12.6±0.52 19.2±0.91 
Data are expressed as mean ± SEM 
 
6.3.6  Biochemical Parameters 
 
Biochemical parameter 
Control 
EchinopsEchinatus Roxb 
200 mg 400mg  
Creatinine (mg/dl) 0.5890±0.079 0.6600 ±  0.049 0.5540 ±  0.074 
Urea (mg/dl) 15.30 ± 0.47 14.50 ± 0.40 15.20 ±0.57 
Triglycerides (mg/dl) 52.20±1.13 51.40±1.08 47.10±1.62 
Total Cholesterol (mg/dl) 46.60±1.21 51.40±1.08 54.03±1.67 
Total protein (mg/dl) 4.40±0.26 4.20±0.35 3.70±0.26 
Albumin (g/dl) 3.20±0.41 3.70±0.33 3.20±0.29 
AST (IU/L) 121.41±2.68 121.3±1.65 116.61±2.045 
ALT (IU/L) 69.40±1.57 67.60±1.301 68.60±1.108 
ALP (IU/L) 112.6±4.67 117.01±0.714 117.41±0.718 
T. Bilirubin (mg/dl) 0.2569±0.32 0.267±0.029 0.254±0.023 
Data are expressed as mean ± SEM 
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6.4 HISTOPATHOLOGY OF VITAL ORGANS  
 
At the end of the 30th day Liver, Kidney, Heart, Lungs and Brain were 
subjected for routine Histopathological examination and fixed in 10 % formal saline 
(10 parts of formaldehyde and 30 parts of normal saline). Tissues were processed 
and embedded in paraffin wax. Sections were cut at 5 micron thickness and stained 
with Haematoxylin and Eosin. Light microscopic examination of the sections was 
then carried out and micrographs produced using Vanox-T Olympus photographing 
microscope. The histopathological examinations were reviewed by the 
pathologist.60 
BRAIN 
         
  
200mg/kg  400mg/kg 
 
HEART 
  
  
200mg/kg 400mg/kg 
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KIDNEY 
 
  
200mg/kg 400mg/kg 
   
 
LIVER 
 
  
200mg/kg 400mg/kg 
        
 
LUNG 
 
  
200mg/kg 400mg/kg 
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ANTI-ULCER ACTIVITY- Acetic Acid Induced ulcerations  
 
Effect of Gastric Volume: 
Group 
No. 
Body 
wt. gms Treatment 
Vol. of gastric 
Juice pH 
I 
180 
165 
175 
250 
210 
205 
 
Control 
 
 
 
 
4.5ml 
5.0ml 
4.6ml 
4.2ml 
5.2ml 
4.2ml 
4.61 ±0.153 
2 
2 
2 
3 
2 
2 
2.16 ± 0.152 
II 
165 
185 
210 
175 
205 
195 
 
dilute acetic acid (4%) 
(2 mL) 
& 
Omeprazole(20mg/kg) 
 
 
2.0ml 
1.8ml 
1.6ml 
2.2ml 
2.8ml 
1.9ml 
2.05 ±0.155 
5 
7 
6 
6 
7 
5 
6 ± 0.333 
III 
200 
195 
180 
165 
210 
215 
 
dilute acetic acid (4%) 
(2 mL) 
& 
Ethanolic 
extract(200mg/kg) 
 
3.2ml 
3.4ml 
2.8ml 
3.5ml 
3.2ml 
3.0ml 
3.18 ±0.104 
4 
4 
4 
5 
4 
3 
4.0 ± 0.258 
IV 
195 
185 
220 
215 
185 
175 
 
 
dilute acetic acid (4%) 
(2 mL) 
& 
Ethanloic extract 
(400mg/kg) 
 
2.8ml 
2.4ml 
2.2ml 
2.4ml 
2.2ml 
2.6ml 
2.43 ±0.09* 
5 
6 
5 
5 
6 
6 
5.5 ± 0.204* 
 
Table: 5. Effect of EE on Gastric Volume and pH in Acetic acid Induced Ulcer 
 
Values are expressed in terms of mean ± SEM of 6 rats (ANOVA) 
*Statistically significant P ≤0.05 (in comparison with Standard). 
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Effect of Free Acidity and Total Acidity: 
 
Group 
No. 
Body 
wt. 
gms Treatment Free acidity Total acidity 
I 
 
 
 
180 
165 
175 
250 
210 
205 
 
Control 
 
 
 
 
24 
20 
22 
19 
24 
22 
21.83 ± 
0.833 
42 
43 
40 
39 
44 
42 
41.66 ± 0.760 
II 
 
 
 
165 
185 
210 
175 
205 
195 
 
dilute acetic acid 
(4%) (2 mL) 
& 
Omeprazole(20mg/
kg) 
 
 
12 
10 
8 
12 
9 
11 
10.33 ± 0.66 
24 
21 
19 
16 
21 
19 
20 ± 1.09 
III 
 
 
 
200 
195 
180 
165 
210 
215 
 
dilute acetic acid 
(4%) (2 mL) 
& 
Ethanolic 
extract(200mg/kg) 
 
14 
16 
18 
17 
18 
16 
16.5 ± 0.61 
32 
31 
35 
28 
34 
30 
31.66 ± 1.05 
IV 
 
 
 
195 
185 
220 
215 
185 
175 
 
dilute acetic acid 
(4%) (2 mL) 
& 
Ethanloic extract 
(400mg/kg) 
 
 
12 
14 
12 
12 
10 
11 
11.8 ± 0.54* 
21 
24 
22 
25 
26 
22 
23.33 ± 0.80* 
 
Table: 6. Effect of EECP on Free Acidity and Total Acidity in Acetic acid Induced Ulcer: 
 
Values are expressed in terms of mean ± SEM of 6 rats (ANOVA) 
*Statistically significant P ≤0.05 (in comparison with Standard). 
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Ulcer index: 
Group 
No 
Body 
Weight 
gm 
ULCER INDEX 
Total 
Score 
Mean 
Ulcer 
Index ± 
SEM 
 
% 
Protecti
on 
Normal 
Colour 
stomach 
Normal 
Colour 
stomach 
Ulcer 
Spots 
Hemorrh-
agic streaks 
Ulcers 
≥3 but 
≤5 
Ulcer 
>5 
I 
180 
165 
175 
250 
210 
205 
- 
- 
- 
- 
- 
- 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
1 
1 
1 
1 
1 
1 
1.5 
1.5 
1.5 
1.5 
1.5 
1.5 
- 
2 
- 
2 
- 
- 
3 
- 
3 
- 
3 
3 
6 
5 
6 
5 
6 
6 
5.666 
±0.192 
45 - 
II 
165 
185 
210 
175 
205 
195 
- 
- 
- 
- 
- 
- 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
1 
- 
1 
- 
- 
- 
- 
- 
- 
- 
- 
1.5 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
1.5 
0.5 
1.5 
0.5 
0.5 
2 
1.083 
±0.247 
6 77.5 
III 
200 
195 
180 
165 
210 
215 
- 
- 
- 
- 
- 
- 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
- 
1 
1 
1 
1 
1 
1.5 
1.5 
- 
1.5 
- 
- 
- 
- 
- 
- 
2 
- 
- 
- 
- 
- 
- 
2 
3 
1.5 
3 
1.5 
3.5 
2.41 
±0.35 57.42 
IV 
195 
185 
220 
215 
185 
175 
- 
- 
- 
- 
- 
- 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
- 
1 
1 
1 
- 
1.5 
1.5 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
2 
2 
1.5 
1.5 
1.5 
0.5 
1.5 
±0.22 73.49* 
 
Table: 7. Effect of EECP on Ulcer Index in Acetic acid- Induced Gastric Ulceration 
 
Values are expressed in terms of mean ± SEM of 6 rats (ANOVA) 
*Statistically significant p ≤ 0.05 (in comparison with Standard). 
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Comparison of all the parameters on Acetic acid induced ulcers 
 
 
 
 
Open excised stomach in Acetic acid induced gastric lesions model: 
 
 
Gastric lesions induced by Acetic acid (2ml) Absence of gastric lesions in Omeprazole 
(20mg/kg) 
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Fraction inhibition in gastric lesions at 
200mg/kg of EE 
Inhibition in gastric lesions at 400mg/kg of 
EECP 
 
 
 
Gastric lesions induced by Acetic acid (2ml) Omeprazole (20 mg/kg) no damage to 
mucosal epithelium was observed. 
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EE(200mg/kg): Apparent epithelisation was 
observed. 
EE (400mg/kg): Apparent epithelisation 
was observed 
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Methylene blue Induced ulcerations 
 
Table: 8. Effect of EE on Gastric Volume and pH: 
Group No. Body wt. gms Treatment Vol. of gastric pH 
   Juice  
I 180  5.0ml 2 
 170  5.0ml 2 
 175 Control 4.8ml 2 
 210  4.4ml 2 
 195  4.8ml 2 
 190  4.6ml 3 
   4.7 ±0.087 2.1 ± 0.152 
II 170  2.0ml 6 
 185 Methylene blue 125 mg/kg 2.2ml 7 
 205 Omeprazole(20mg/kg) 1.8ml 7 
 185  2.4ml 6 
 210  2.8ml 7 
 180  2.0ml 5 
   2.24 ±0.172 6.3 ±0.304 
III 190  3.0ml 6 
 195  3.2ml 6 
 180 Methylene blue 125 mg/kg  3.6ml 4 
 170 Ethanolic 3.4ml 4 
 215 extract(200mg/kg) 3.2ml 6 
 205  3.2ml 7 
   3.2 ±0.08 5.4 ±0.6* 
     
IV 190  2.0ml 5 
 185  2.8ml 6 
 215 Methylene blue 125 mg/kg 2.4ml 6 
 190 Ethanolic extract 2.2ml 7 
 185 (400mg/kg) 2.8ml 5 
 180  3.0ml 6 
   2.5 ±0.160* 6 ±0.316** 
     
 
 
Values are expressed in terms of mean ± SEM of 6 rats (ANOVA) 
 
*Statistically significant p ≤ 0.05 (in comparison with Standard). 
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Table: 9. Effect of EE on Free Acidity and Total Acidity: 
 
    Total Acidity 
Group No. Body wt. gms Treatment Free Acidity  
I 180  20 42 
 170  18 46 
 175 Control 21 40 
 210  19 42 
 195  22 40 
 190  24 39 
   20.6 ±0.88 41.5 ±.1.02 
II 170  10 18 
 185  8 26 
 205 
Methylene blue 
125 mg/kg 12 20 
 185 Omeprazole(20mg/kg) 10 22 
 210  14 19 
 180  8 24 
   10.33 ±0.95 21.5 ±1.25 
III 190  14 32 
 195  14 36 
 180 
Methylene blue  
125 mg/kg 11 34 
 170 
Ethanolic 
extract(200mg/kg) 18 32 
 215  16 28 
 205  18 32 
   15.66 ±1.10 32.3 ±1.085 
IV 190  12 26 
 185  14 24 
 215 
Methylene blue 
125 mg/kg 12 22 
 190 Ethanolic extract 10 22 
 185 (400mg/kg) 9 26 
 180  10 24 
   11.16 ±0.74* 24 ±0.73* 
 
 
 
Values are expressed in terms of mean ± SEM of 6 rats (ANOVA) 
*Statistically significant P ≤ 0.05 (in comparison with Standard). 
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Table: 10. Effect of EECP on Ulcer Index in Methylene Blue -Induced gastric ulceration 
(Mean ± SE, n=6 in each group) 
 
Grou
p 
No 
Body 
Weigh
t  
gm 
ULCER INDEX 
Total 
Scor
e  
 
Mean 
Ulcer 
Index 
± SEM  
 
% 
Protectio
n 
Normal 
Colour 
stomac
h  
 
Normal 
Colour 
stomac
h  
 
Ulcer 
Spot
s  
 
Hemorrh
-agic 
streaks  
 
Ulcer
s ≥3 
but ≤5  
 
Ulcer>
5  
 
I 
180 
170 
175 
210 
195 
190 
- 
- 
- 
- 
- 
- 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
1 
1 
1 
1 
1 
1 
1.5 
1.5 
1.5 
1.5 
1.5 
1.5 
- 
- 
- 
2 
- 
- 
3 
3 
3 
- 
3 
3 
6 
6 
6 
5 
6 
6 
5.83 
±0.16
6 - 
II 
170 
185 
205 
180 
210 
180 
- 
- 
- 
- 
- 
- 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
1 
- 
1 
1 
- 
- 
- 
- 
- 
- 
1.5 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
1.5 
0.5 
1.5 
1.5 
2 
0.5 
1.25 
±0.22
8 78.55 
III 
190 
195 
185 
170 
215 
205 
- 
- 
- 
- 
- 
- 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
1 
1 
1 
1 
- 
1 
- 
1.5 
1.5 
- 
1.5 
1.5 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
1.5 
3 
3 
1.5 
2 
3 
2.33 
±0.30
7 60.04 
IV 
190 
185 
215 
190 
185 
180 
- 
- 
- 
- 
- 
- 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
- 
1 
- 
- 
- 
1 
1.5 
- 
1.5 
1.5 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
2 
1.5 
2 
2 
0.5 
1.5 
1.58 
±0.23 72.89* 
 
Values are expressed in terms of mean ± SEM of 6 rats (ANOVA)  
*Statistically significant P ≤ 0.05 (in comparison with Standard). 
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Open excised stomach in methylene blue induced gastric lesions model: 
 
 
Gastric lesions induced by (30mg/kg) Absence of gastric lesions in Omeprazole 
(20mg/kg) 
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Fraction inhibition in gastric lesions at 
200mg/kg of EECP 
Inhibition in gastric lesions at 400mg/kg of 
EECP 
 
 
 
 
 
 damaged mucosal epithelium was 
observed 
no damage to mucosal epithelium was 
observed. 
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apparent epithelisation was observed. apparent epithelisation was observed 
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ANTI-OXIDANT ACTIVITY 
 
DPPH radical scavenging assay: 
Table: 11. DPPH assay of Ethanolic extract of Echinops echinatus Roxb 
 
S. No 
Concentration 
% of inhibition IC50 value 
 
In µg/ml 
 
    
     
1 1000 92.6 
47±1.8.* 
 
 
2 500 78.4 
 
 
3 250 71.4 
 
 
4 125 62.4 
 
 
5 61.5 56.4 
 
 
6 31.2 35.9 
 
 
7 15.6 15.1 
 
 
8 Control 0 
 
 
9 Standard 
Rutin 
- 43.60±1.79 
 
 
  
Values are the average of (n=3) and represented as mean ± standard deviation and 
probability value * P ≤ 0.05 significant when IC50 values are compared with standard. 
 
Figure: 25 DPPH radical scavenging assay IC50 value
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Nitric oxide scavenging assay: 
 
Table: 12, Nitric oxide radical scavenging activity of Ethanolic extract of Echinops 
echinatus Roxb 
 
S. No 
Concentration 
% of inhibition IC50 value 
 
in µg/ml 
 
    
     
1 
1000 68.33   
    
2 500 60.8   
     
3 250 55   
   
63± 1.6 * 
 
4 125 54.1  
     
5 61.5 50.8   
     
6 31.2 42.5   
     
7 15.6 27.5   
     
8 Control 0   
     
9 Standard - 65.44  
 Rutin    
     
Values are the average of (n=3) and represented as mean ± standard deviation and 
probability values 
* P ≤ 0.05; significant when IC50 values are compared with standard values. 
Nitric oxide scavenging assay: 
 
 
Fig no: 26 Nitric oxide radical scavenging assay IC50 values 
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VII. DISCUSSION 
 
 The etiology of peptic ulcer is unknown in most of the cases, yet it is generally 
accepted that it results from an imbalance between aggressive factors and the 
maintenance of mucosal integrity through the endogenous defence mechanisms. To 
regain the balance, different therapeutic agents including plant extracts are used (in 
experimental animals) to inhibit the gastric acid secretion or to boost the mucosal 
defence mechanisms by increasing mucus production, stabilizing the surface epithelial 
cells or enhancing prostaglandin synthesis.72 
 Though a very good numbers of anti-ulcers drugs like antisecretory drugs, H2 
receptor antagonists, proton pump inhibitors, antimuscaranic, cytoprotectants and 
Prostaglandins analogues are available; the side effects associated with these drugs 
limit their use. Many herbal drugs from Ayurveda of Indian traditional system of 
medicine are advocated for the management of peptic ulcer. Herbal medicines are 
used as plant extracts from different parts are now a days consider as safe medication 
for the treatment of a number of diseases as it is a general notion that plant based 
drugs are safer without any side effects. 
 Though the presently available anti-ulcer drugs have remarkable effects in ulcer 
therapy the efficacy is still incomplete as there are many a number of incidences of 
relapse with adverse effects and drug-drug interaction are reported with the therapy. 
Hence there is a need for ideal anti-ulcer drugs with extended action from herbal 
source with a caliber of better protection and low incidence of relapse of ulcers.78 
 In Indian system of medicine a very good numbers of herbs are reported to 
produce antiulcer and anti-inflammatory activities. Hence in the present study Echinops 
echinatus Roxb (whole plant) posses antiulcer activity in Acetic acid and Methylene 
Blue induced ulcer model. 
 The present results demonstrate that the ethanolic extract of Echinops echinatus 
Roxb whole plant protect the rat gastric mucosa against hemorrhagic lesion produced 
by acetic acid and methylene blue. These inducing methods of gastric lesions are rapid 
and convenient way of screening plant extracts for antiulcer potency and cytoprotection 
in macroscopically and microscopically visible lesions.89 
   76 
 
acetic acid and methylene blue induced gastric ulcers has been widely used for the 
experimental evaluation of antiulcer activity. Acetic acid induced and Methylene Blue  
induced gastric lesion formation may be due to stasis in gastric blood flow, which 
contributes to the development of the hemorrhagic and necrotic aspect of tissue injury. 
NSAID’s like acetic acid causes gastric mucosal damage by decreasing prostaglandin 
levels through inhibition of PG synthesis.92 
 Tannins83, flavonoids84, glycosides85, triterpenes86 and Phytosterols87 are 
reported for their anti-ulcer activity. All the above mentioned phytoconstituents are 
present in Echinops echinatus Roxb and hence might have contributed for anti ulcer 
activity.94 
Echinops echinatus Roxb has significantly protected the gastric mucosa against acetic 
acid and methylene blue challenge as shown by reduced values of lesion index as 
compared to solvent control group suggesting its potent cytoprotective effect. It shows 
significant inhibition of formation of gastric ulcer and also decreases both acid 
concentration, gastric volume and increased the pH values. It suggests that Ethanolic 
extract of Echinops echinatus Roxb can suppress the gastric damage induced by 
aggressive factors. 
Echinops echinatus Roxb extract was significantly effective in protecting gastric 
mucosa against Acetic acid induced ulcers at different dose level studied. Methylene 
Blue  induced gastric injury is associated with significant production of oxygen free 
radicals leading to increased lipid peroxidation, this causes damage to cell and cell 
membrane.96 
 Reactive oxygen species, reactive nitrogen species, reactive carbonyl species 
are products of normal cellular metabolism, act as a secondary messenger controlling 
various normal physiological functions of organs. Oxidative stress seems to be cause 
many diseases particularly in inflammation, diabetes, cancer, gastric disorders and 
other many other diseases. This situation motivates research on naturally occurring 
anti-oxidants from plants, organism known to have developed efficient systems that 
protect them against environmental oxidative stress. Bio molecules of remarkable 
structural diversity, plant anti-oxidants are results of millions of years of evolutionary 
optimization, with view to achieving a perfect functionality. 
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 The free radical scavenging activity of extract of Echinops echinatus Roxb. was 
evaluated based on the ability of quench the synthetic DPPH. The assay provides 
useful information on reactivity of the compounds with free radicals. DPPH absorption 
represents the capacity of test compound to scavenge free radical independently. The 
extract possessed significant DPPH radical scavenging activity compared with 
standard rutin. 
 Nitric oxide is a mediator of physiological processes such as smooth muscle 
relaxation, neuronal signalling, inhibition of platelet aggregation and regulation of cell 
mediated toxicity. It is diffusible free radical which plays many roles as effectors 
molecules in diverse biological systems including vasodilatation, antimicrobial and 
antitumor activity. Scavenging of nitric oxide compete with oxygen leading to the 
reduced production nitric oxide.The scavenging activity of Echinops echinatus Roxb 
extract shows significant effect on anti-oxidant activity. The extract of Nitric oxide 
scavenging activity compared with standard rutin.89 
 The phytochemical screening of the extract of Echinops echinatus Roxb revealed 
the presence of alkaloids, flavonoids and Triterpenoids. Any of these metabolites may 
be responsible for the anti-oxidant and anti-ulcer properties of Echinops echinatus 
Roxb 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   78 
 
VIII. CONCLUSION 
 
From the present study it was concluded that the preliminary phytochemical evaluation 
of Ethanolic extract of Echinops echinatus Roxb revealed the presence of tannins, 
sterols, flavonoids, glycosides, alkaloids and triterpenes. 
 
Acute oral toxicity studies shows no mortality recorded with the extracts even at the 
dose level of 2000 mg/kg body weight. 
 
From the results of present study it was concluded that the ethanolic extract of 
Echinops echinatus Roxb (whole plant) at 400mg/kg shows significant anti-ulcer activity 
in animals models used, as compared to the standard drug Omeprazole. The positive 
anti-oxidant activities in different methods further confirm its protection against gastro 
duodenal pathogenesis. 
 
The present study clearly demonstrated the antiulcer and antioxidant property of 
ethanolic extract of Echinops echinatus Roxb. These effects may be due to the 
presence of tannins, alkaloids, flavonoids, and triterpenes observed in the extract. 
 
These finding thus prompt further necessary study to carry out the elucidation of 
mechanism of actions related to anti ulcer and anti oxidant activity in molecular levels, 
by which more effective treatment for the disorders can be achieved. 
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